Title
of each class
|
Name
of each exchange on which registered
|
Subordinate
Voting Shares without par value
|
NASDAQ
|
Subordinate
Voting Shares without par value
|
TSX
|
Large
accelerated filer o
|
Accelerated
filer x
|
Non-accelerated
filer o
|
A. |
Selected Financial Data
|
Years
ended August 31,
|
||||||||||||||||
2006
|
2005
|
2004
|
2003
|
2002
|
||||||||||||
(in
thousands of US dollars, except share and per share
data)
|
||||||||||||||||
Consolidated
Statements of Earnings Data:
|
||||||||||||||||
Amounts
under Canadian GAAP
|
||||||||||||||||
Sales
|
$
|
128,253
|
$
|
97,216
|
$
|
74,630
|
$
|
61,930
|
$
|
68,330
|
||||||
Cost
of sales (1)
|
57,275
|
44,059
|
34,556
|
36,197
|
52,366
|
|||||||||||
Gross
margin
|
70,978
|
53,157
|
40,074
|
25,733
|
15,964
|
|||||||||||
Operating
expenses
|
||||||||||||||||
Selling
and administrative
|
40,298
|
31,782
|
25,890
|
26,991
|
33,881
|
|||||||||||
Net
research and development
|
15,404
|
12,190
|
12,390
|
15,879
|
12,782
|
|||||||||||
Amortization
of property, plant and equipment
|
3,523
|
4,256
|
4,935
|
5,210
|
5,096
|
|||||||||||
Amortization
of intangible assets
|
4,394
|
4,836
|
5,080
|
5,676
|
12,451
|
|||||||||||
Impairment
of long-lived assets and goodwill
|
604
|
−
|
620
|
7,427
|
23,657
|
|||||||||||
Government
grants
|
(1,307
|
)
|
−
|
−
|
−
|
−
|
||||||||||
Restructuring
and other charges
|
−
|
292
|
1,729
|
4,134
|
2,880
|
|||||||||||
Total
operating expenses
|
62,916
|
53,356
|
50,644
|
65,317
|
90,747
|
|||||||||||
Earnings
(loss) from operations
|
8,062
|
(199
|
)
|
(10,570
|
)
|
(39,584
|
)
|
(74,783
|
)
|
|||||||
Interest
and other income
|
3,253
|
2,524
|
1,438
|
1,245
|
1,456
|
|||||||||||
Foreign
exchange loss
|
(595
|
)
|
(1,336
|
)
|
(278
|
)
|
(1,552
|
)
|
(458
|
)
|
||||||
Earnings
(loss) before income taxes and amortization and write-down of
goodwill
|
10,720
|
989
|
(9,410
|
)
|
(39,891
|
)
|
(73,785
|
)
|
||||||||
Income
taxes
|
2,585
|
2,623
|
(986
|
)
|
15,059
|
(25,451
|
)
|
|||||||||
Earnings
(loss) before amortization and write-down of goodwill
|
8,135
|
(1,634
|
)
|
(8,424
|
)
|
(54,950
|
)
|
(48,334
|
)
|
|||||||
Amortization
of goodwill
|
−
|
−
|
−
|
−
|
38,021
|
|||||||||||
Write-down
of goodwill
|
−
|
−
|
−
|
−
|
222,169
|
|||||||||||
Net
earnings (loss) for the year
|
$
|
8,135
|
$
|
(1,634
|
)
|
$
|
(8,424
|
)
|
$
|
(54,950
|
)
|
$
|
(308,524
|
)
|
||
Basic
and diluted net earnings (loss) per share
|
$
|
0.12
|
$
|
(0.02
|
)
|
$
|
(0.13
|
)
|
$
|
(0.87
|
)
|
$
|
(5.09
|
)
|
||
Basic
weighted average number of shares used in per share calculations
(000’s)
|
68,643
|
68,526
|
66,020
|
62,852
|
60,666
|
|||||||||||
Other
consolidated statements of earnings data:
|
||||||||||||||||
Gross
research and development
|
$
|
19,488
|
$
|
15,878
|
$
|
15,668
|
$
|
17,133
|
$
|
17,005
|
||||||
Net
research and development
|
$
|
15,404
|
$
|
12,190
|
$
|
12,390
|
$
|
15,879
|
$
|
12,782
|
||||||
Amounts
under U.S. GAAP
|
||||||||||||||||
Net
earnings (loss) for the year
|
$
|
8,135
|
$
|
(2,920
|
)
|
$
|
(9,571
|
)
|
$
|
(48,201
|
)
|
$
|
(382,893
|
)
|
||
Basic
and diluted net earnings (loss) per share
|
$
|
0.12
|
$
|
(0.04
|
)
|
$
|
(0.14
|
)
|
$
|
(0.77
|
)
|
$
|
(6.31
|
)
|
||
Basic
weighted average number of shares used in per share calculations
(000’s)
|
68,643
|
68,526
|
66,020
|
62,852
|
60,666
|
As
at August 31,
|
||||||||||||||||
2006
|
2005
|
2004
|
2003
|
2002
|
||||||||||||
(in
thousands of US dollars)
|
||||||||||||||||
Consolidated
Balance Sheets Data:
|
||||||||||||||||
Amounts
under Canadian GAAP
|
||||||||||||||||
Cash
|
$
|
6,853
|
$
|
7,119
|
$
|
5,159
|
$
|
5,366
|
$
|
9,128
|
||||||
Short-term
investments
|
104,437
|
104,883
|
83,969
|
52,010
|
40,553
|
|||||||||||
Working
capital
|
143,985
|
135,288
|
115,141
|
76,659
|
91,374
|
|||||||||||
Total
assets
|
219,159
|
190,957
|
172,791
|
146,254
|
177,926
|
|||||||||||
Long-term
debt (excluding current portion)
|
354
|
198
|
332
|
453
|
564
|
|||||||||||
Share
capital
|
148,921
|
521,875
|
521,733
|
492,452
|
489,611
|
|||||||||||
Shareholders’
equity
|
$
|
196,234
|
$
|
173,400
|
$
|
157,327
|
$
|
129,826
|
$
|
165,406
|
||||||
Amounts
under U.S. GAAP
|
||||||||||||||||
Cash
|
$
|
6,853
|
$
|
7,119
|
$
|
5,159
|
$
|
5,366
|
$
|
9,128
|
||||||
Short-term
investments
|
104,437
|
104,883
|
83,969
|
52,010
|
40,553
|
|||||||||||
Working
capital
|
149,436
|
138,225
|
117,116
|
78,225
|
91,305
|
|||||||||||
Total
assets
|
212,702
|
182,852
|
164,758
|
138,020
|
161,314
|
|||||||||||
Long-term
debt (excluding current portion)
|
354
|
198
|
332
|
453
|
564
|
|||||||||||
Share
capital
|
598,421
|
597,664
|
596,309
|
565,291
|
560,943
|
|||||||||||
Shareholders’
equity
|
$
|
189,777
|
$
|
165,295
|
$
|
149,294
|
$
|
121,592
|
$
|
150,999
|
(1)
|
The
cost of sales is exclusive of amortization, shown separately. Includes
inventory write-offs of nil, nil, nil, $4,121,000 and $18,463,000
for the
years ended August 31, 2006, 2005, 2004, 2003 and 2002, respectively,
and
an unusual gain of $473,000 for the year ended August 31,
2003.
|
· |
Increased
competition for business;
|
· |
Reduced
demand;
|
· |
Limited
number of potential customers;
|
· |
Competition
from companies with lower production costs, including companies operating
in lower cost environments;
|
· |
Introduction
of new products by competitors;
|
· |
Greater
economies of scale for higher-volume
competitors;
|
· |
Large
customers, who buy in high volumes, can exert substantial negotiating
leverage over us;
|
· |
Resale
of used equipment; and
|
· |
Equipment
sales resulting from manufacturing and rental company
bankruptcies.
|
· |
Costly
repairs;
|
· |
Product
returns or recalls;
|
· |
Damage
to our brand reputation;
|
· |
Loss
of customers, failure to attract new customers or achieve market
acceptance;
|
· |
Diversion
of development and engineering
resources;
|
· |
Legal
actions by our customers, including claims for consequential damages
and
loss of profits; and
|
· |
Legal
actions by governmental entities, including actions to impose product
recalls and/or forfeitures.
|
· |
Issue
shares that would dilute individual shareholder percentage
ownership;
|
· |
Incur
debt;
|
· |
Assume
liabilities and commitments;
|
· |
Incur
significant expenses related to amortization of additional intangible
assets;
|
· |
Incur
significant impairment losses of goodwill and intangible assets related
to
such acquisitions; and
|
· |
Incur
losses from operations.
|
· |
Risk
of not realizing the expected benefits or synergies of such
acquisitions;
|
· |
Problems
integrating the acquired operations, technologies, products and
personnel;
|
· |
Risks
associated with the transfer of acquired know-how and
technology;
|
· |
Unanticipated
costs or liabilities;
|
· |
Diversion
of management’s attention from our core
business;
|
· |
Adverse
effects on existing business relationships with suppliers and
customers;
|
· |
Risks
associated with entering markets in which we have no or limited prior
experience; and
|
· |
Potential
loss of key employees, particularly those of acquired
organizations.
|
· |
Length
of the product sales cycle for certain products, especially those
that are
higher priced and more complex;
|
· |
Timing
of product launches and market acceptance of new products for us
as well
as our competitors;
|
· |
Our
ability to sustain product volumes and high levels of quality across
all
product lines;
|
· |
Timing
of shipments for large orders;
|
· |
Effect
of seasonality on sales and bookings;
and
|
· |
Losing
key accounts and not successfully developing new
ones.
|
· |
Fluctuating
demand for telecommunications test and measurement equipment as well
as
life sciences and industrial
solutions;
|
· |
Changes
in the capital spending and operating budgets of our customers, which
may
cause seasonal or other fluctuations in product mix, volume, timing
and
number of orders we receive from our
customers;
|
· |
Order
cancellations or rescheduled delivery
dates;
|
· |
Pricing
changes by our competitors or
suppliers;
|
· |
Customer
bankruptcies and difficulties in collecting accounts
receivable;
|
· |
Restructuring
and impairment charges; and
|
· |
General
economic conditions.
|
· |
Properly
identify and anticipate customer
needs;
|
· |
Innovate
and develop new products;
|
· |
Gain
timely market acceptance for new
products;
|
· |
Manufacture
and deliver our new products on time and in sufficient
volume;
|
· |
Price
our products competitively;
|
· |
Continue
investing in our research and development programs;
and
|
· |
Anticipate
competitors’ announcements of new
products.
|
· |
Challenges
in staffing and managing foreign operations due to the limited number
of
qualified candidates, employment laws and practices in foreign countries,
any of which could increase the cost and reduce the efficiency of
operating in foreign countries;
|
· |
Our
ability to comply with import/export, environmental and other trade
compliance regulations of the countries in which we do business,
together
with unexpected changes in such
regulations;
|
· |
Adhering
to laws, regulations and contractual obligations relating to customer
contracts in various countries;
|
· |
Difficulties
in establishing and enforcing our intellectual property
rights;
|
· |
Maintaining
a competitive list of distributors for indirect
sales;
|
· |
Tariffs
and other trade barriers;
|
· |
Economic
instability in foreign markets;
|
· |
Wars,
acts of terrorism and political
unrest;
|
· |
Language
and cultural barriers;
|
· |
Integration
of foreign operations;
|
· |
Currency
fluctuations;
|
· |
Potential
foreign and domestic tax
consequences;
|
· |
Technology
standards that differ from those on which our products are based,
which
could require expensive redesign and retention of personnel familiar
with
those standards;
|
· |
Longer
accounts receivable payment cycles and possible difficulties in collecting
payments which may increase our operating costs and hurt our financial
performance; and
|
· |
Certification
requirements.
|
· |
Our
OmniCure product line, focused on UV spot-curing applications, has
enjoyed
significant growth within the medical and optoelectronics
industries. These diverse markets, largely influenced by the
miniaturization trend, are expanding worldwide with Asia showing
the
largest year-over-year growth.
|
· |
Our
X-Cite series, an add-on illumination system for high-end microscopes,
has
entrenched itself as a market leader in various research areas. The
global
fluorescence microscopy market is growing in mid single digits, while
live
cell and quantitative imaging are increasingly gaining
traction.
|
· |
Our
Burleigh nano-positioning product line, mainly designed for cellular
micromanipulation, continues to demonstrate strong brand-name recognition
and loyal following with electrophysiologists. It targets a stable
growth
market focused on fundamental neuroscience and drug
discovery.
|
· |
Grow
revenues by 20% year-over-year. We
were among the last companies to be impacted by the telecommunications
downturn in 2001 and first to recover with sales growth of 20.5%
in fiscal
2004, 30.3% in 2005 and 31.9% in 2006, including 12 consecutive
quarters of growth. This recovery was accomplished mainly through
market-share gains, since our end-markets reportedly experienced
negative
growth in fiscal 2004 and increased in the mid single digits in 2005
and
2006. We will strive to maintain a high growth rate in 2007 by seeking
to
further increase our market share in telecom testing, especially
in the
rapidly growing protocol test segment, and by seeking to leverage
core
technologies in targeted life sciences and industrial markets.
|
· |
Generate
a GAAP earnings from operations of 7%. Our
bottom-line improved faster than our top-line in the last few years
with a
GAAP earnings from operations of 6.3% in fiscal 2006. We expect that
our
GAAP earnings from operations will continue to improve in 2007 as
we
expect that higher-margin protocol revenues, better absorption of
fixed
costs on higher sales volumes, specific internal initiatives, and
currency
stability will come into play.
|
· |
Derive
35% of sales from new products (on the market two years or less).
Despite
missing this aggressive innovation target in recent years, our new
products, with their built-in superior performance and lower cost
of
goods, contributed significantly to raising our gross margin and
earnings
from operations. We are maintaining this innovation metric for 2007
based
on our market-driven focus and enhanced portfolio of new products
(18 new
products) released in the past
year.
|
· |
Unlike
stand-alone units, new test modules can be rapidly developed to address
changing industry requirements.
|
· |
As
customers’ testing requirements change, they can purchase additional
modules that are compatible with their previously purchased platforms,
thus protecting their initial
investments.
|
· |
Our
standard graphical user interface reduces training costs because
customers
are familiar with previously acquired software
products.
|
· |
The
flexibility of our systems allows customers to develop customized
and
automated solutions for their specific test
requirements.
|
· |
Our
test platforms are PC-based and Windows-driven, thus they can support
third-party software solutions.
|
· |
The
first PC-based modular test platform for field
applications;
|
· |
The
first all-in-one optical loss test set combining several
instruments;
|
· |
The
first portable polarization mode dispersion (PMD)
analyzer;
|
· |
The
first modular platform to combine optical and protocol test
solutions;
|
· |
The
first line of portable test instruments designed for FTTx testing;
and
|
· |
The
first fully integrated Ethernet-over-SONET test
solution.
|
Format
|
||||||
Instrument
Type
|
Typical
Application
|
NSP
Market
|
Manufacturer/R&D
Market
|
|||
FTB
400
Modules
|
FTB
200 Modules
|
Handhelds
|
IQS-500
Modules
|
Benchtop
Instruments
|
||
ADSL/ADSL2+
Service Verification Tool
|
Based
on a DSL “golden modem”, these units are used to test the function, speed
and quality of a DSL service at the subscriber premises.
|
X
|
||||
Broadband
source
|
Used
for testing wavelength-dependent behavior of fiber cables and DWDM
optical
components.
|
X
|
X
|
|||
Chromatic
dispersion analyzer
|
Measures
increasing levels of chromatic dispersion in high-capacity optical
networks. Chromatic dispersion is a physical phenomenon inherent
to
optical fiber and optical components that causes information bits
to
spread along a network. This degrades the quality of the transmission
signal and, in turn, limits the transmission speed carried by optical
networks.
|
X
|
||||
Clip-on
coupling device
|
Clips
to an optical fiber and allows non-invasive testing.
|
X
|
||||
Format
|
||||||
Instrument
Type
|
Typical
Application
|
NSP
Market
|
Manufacturer/R&D
Market
|
|||
FTB
400
Modules
|
FTB
200 Modules
|
Handhelds
|
IQS-500
Modules
|
Benchtop
Instruments
|
||
Fibre
Channel tester
|
Brings
FC-0, FC-1 and FC-2 logical layer Fibre Channel testing to services
delivered via
transport protocols,
such as DWDM, SONET/SDH
and dark fiber. It provides valuable timing information and buffer
credit
estimation for Fibre Channel network deployment.
|
X
|
X
|
|||
Gigabit
Ethernet tester
|
Measures
data integrity for high-speed Internet protocol telecommunications
in
metro and edge networks.
|
X
|
X
|
X
|
||
10
Gigabit Ethernet tester
|
Benchmarks
and verifies high-speed 10 Gbit/s Ethernet network performance and
service-level agreements.
|
X
|
X
|
X
|
||
HDTV,
SDTV and IPTV service test instrument
|
Used
to test the quality and functionality of standard and high definition
television signals that are delivered over higher-rate ADSL, ADSL2+
and
VDSL2 transmission technologies.
|
X
|
||||
Laser
wavelength meter
|
Performs
high-accuracy, absolute wavelength measurements of continuous wave
(CW)
laser sources.
|
X
|
||||
Laser
spectrum analyzer
|
Performs
high-resolution, spectral characterization of continuous CW laser
sources
|
X
|
||||
Telephone
for traditional voice and VoIP service testing
|
Used
by telephone line and DSL installers to test the proper functioning
of
both traditional and next-generation voice and data communication
services.
|
X
|
||||
Live
fiber detector
|
Clips
on to a fiber and is used to detect the presence and direction of
a signal
without interrupting the traffic.
|
X
|
||||
Loss
test set
|
Integrates
a power meter and a light source to manually or automatically measure
the
loss of optical signal along a fiber.
|
X
|
X
|
X
|
X
|
X
|
Multiwavelength
meter
|
Measures
the power and drift for multiple wavelengths in a DWDM
system.
|
X
|
X
|
X
|
||
Narrowly
tunable laser
|
A
laser that can be precisely tuned to simulate a DWDM light sources.
Used
primarily for testing optical amplifiers.
|
X
|
||||
Next-generation
SONET/SDH analyzer
|
Full
SONET/SDH protocol testing functionality, including support for GFP,
V.CAT, and LCAS next generation enhancements.
|
X
|
X
|
|||
Optical
amplifier
|
Boosts
the power of laser sources. Used for the testing and calibration
of test
systems.
|
X
|
||||
Optical
coupler
|
Used
in test system to combine sources or signals. Also used as splitters
to
monitor signals.
|
X
|
Format
|
||||||
Instrument
Type
|
Typical
Application
|
NSP
Market
|
Manufacturer/R&D
Market
|
|||
FTB
400
Modules
|
FTB
200 Modules
|
Handhelds
|
IQS-500
Modules
|
Benchtop
Instruments
|
||
Optical
fiber parameter analyzer
|
Measures
the geometric and light guiding properties of an optical fiber. Used
in
new fiber research and development and quality control
applications.
|
X
|
||||
Optical
power meter
|
Measures
the power of an optical signal. It is the basic tool for the verification
of transmitters, amplifiers and optical transmission path
integrity.
|
X
|
X
|
X
|
X
|
X
|
Optical
power reference module
|
Provides
a highly accurate and traceable measurement of power for the calibration
or verification of other power measurement instruments.
|
X
|
||||
Optical
return loss meter
|
Combines
a laser and a power meter to measure the amount of potentially degrading
back reflection.
|
X
|
X
|
X
|
X
|
|
Optical
spectrum analyzer
|
Produces
a graphical representation of power versus wavelength for an optical
signal. Useful for measuring the drift, power and signal-to-noise
ratio
for each wavelength in a DWDM system.
|
X
|
||||
Optical
switch
|
Provides
switching between fibers. Used to provide flexible and automated
test
setups such as the measurement of multiple fibers or components with
multiple ports with one instrument.
|
X
|
X
|
|||
Optical
time domain reflectometer
(OTDR)
|
Like
a radar, it measures the time of arrival of reflections of an optical
signal to determine the distance to the breaks or points of excessive
loss
in a fiber network.
|
X
|
X
|
X
|
||
Optical
waveguide analyzer
|
Provides
the refractive index profile of glass and fused silica-based devices
used
in next generation networks.
|
X
|
||||
Passive
component analyzer
|
Characterizes
passive wavelength-selective devices, such as multiplexers, demultiplexers
and add/drop filters, with respect to absolute wavelength in order
to
guarantee their performance within DWDM systems.
|
X
|
||||
Passive
optical network (PON) power meter
|
Determines
the power level of various signal types, including continuous (e.g.,
TV
signal at 1550 nm) and framed (e.g., ATM or Ethernet at 1490 nm or
1310
nm) within a passive optical network. Various baud rates are covered,
ranging from 155 Mbit/s to 2.5 Gbit/s, for both synchronous and
non-synchronous signals.
|
X
|
||||
Polarization-dependent
loss meter
|
Measures
the difference in loss of power for the different states of
polarization.
|
X
|
||||
Polarization
mode dispersion analyzer
|
Measures
the dispersion of light that is caused by polarization. Generally
used to
determine the speed-distance limitation of fiber and
cables.
|
X
|
||||
SONET/
SDH analyzer
|
Provide
accurate bit-error rate and performance analysis of SONET/SDH overhead
format that reflect the quality of a transmission system.
|
X
|
X
|
X
|
Format
|
||||||
Instrument
Type
|
Typical
Application
|
NSP
Market
|
Manufacturer/R&D
Market
|
|||
FTB
400
Modules
|
FTB
200 Modules
|
Handhelds
|
IQS-500
Modules
|
Benchtop
Instruments
|
||
Stable
light source
|
Emitting
diode or lasers used in connection with a power meter to measure
signal
loss.
|
X
|
X
|
X
|
X
|
|
Synchronization
analyzer
|
Portable,
stand-alone tester for network synchronization analysis and wander
measurement in wireless and wireline transport networks.
|
X
|
||||
Talk
set
|
A
device that attaches to an optical fiber and serves as a temporary
voice
link facilitating coordination of work among installation
crews.
|
X
|
X
|
|||
Telephone
wire analyzer
|
Used
by telecommunications service providers that have networks that are
comprised mostly or partially of twisted-pair local loops to ensure
that
those loops are of sufficient quality to carry higher-frequency signals
required for DSL.
|
X
|
||||
Variable
optical attenuator
|
Used
in network simulation setups to provide calibrated variable reduction
of
the strength of an optical signal.
|
X
|
X
|
X
|
||
Visual
fault locator
|
A
visible laser that can be connected to an optical fiber network to
help
locate breaks or points of excessive loss.
|
X
|
X
|
X
|
||
Widely
tunable laser
|
Can
produce laser light across a broad range of wavelengths. Used to
test DWDM
components and value-added optical modules.
|
X
|
X
|
· CWDM/FTTH
passive optical component test system
|
Used
to automatically characterize all critical specifications, including
spectral insertion loss, polarization-dependent loss and optical
return
loss of a CWDM passive component or a FTTH splitter with a high degree
of
accuracy, ease of use and speed.
|
· Cable
assembly and component test system
|
Used
to perform insertion loss and mandrel-free reflection measurements
with
the highest degree of accuracy and repeatability on short fiber assemblies
(including multifiber patchcords, hybrids and fan-out patchcords)
and
components like PLC splitters and fiber arrays.
|
· DWDM
passive component test system
|
Used
to automatically characterize all critical specifications, including
spectral insertion loss, polarization-dependent loss and optical
return
loss of a DWDM passive component with a high degree of accuracy,
ease of
use and speed.
|
Light
Sources and Accessories
|
||
Product
Type
|
Product
|
Typical
Application
|
UV
Light Sources
|
Novacure®
Acticure®
Omnicure®
S1000
Omnicure®
S2000
|
Used
to initiate photo chemical reactions in polymer-based materials for
a
variety of end use applications. Examples include adhesive curing
for
manufacturing of high value-added items such as medical devices,
micro-electronic and opto-electronic components, displays, and data
storage devices.
|
Fluorescent
Light Sources
|
X-Cite®
120XL
X-Cite®
120 PC
|
Fluorescence
light source that attaches directly to most microscopes currently
sold by
major microscopes manufacturers.
|
Computer
Control Module
|
ACS-1000
|
Electronic
interface module used to connect EXFO UV light sources to computers
or
computer networks for process automation.
|
Optical
Accessories
|
Optional
custom delivery optics used with EXFO UV light sources to tailor
the
properties of the light beam to end-user applications.
|
|
High
Power Fiber Light Guide
|
Provides
an equal distribution of light energy to multiple cure sites with
50% more
throughput than standard fiber guides.
|
|
Optical Instruments
|
||
Product
Type
|
Product
|
Typical
Application
|
Radiometer
|
R5000
R2000
|
Handheld,
broadband optical radiometers used in conjunction with EXFO UV light
sources to ensure process quality control at the end-user
location.
|
Cure-Site
Radiometer
|
Attachments
for the R2000 and R5000 radiometers that enable optical measurements
under
customer specific configurations. Examples include the cure-ring
radiometer, which measures the output power of light from an EXFO
cure
ring; ideal for applications that requires a uniform 360°
exposure.
|
|
Precise
Motors/Stages
|
IW-700
Inchworm Motors
|
High-resolution
optical alignment, fiber-optic alignment, semiconductor positioning,
materials research.
|
TSE-820
Inchworm Stages
|
||
UHVL
Inchworm Motors
|
||
Precision
Positioning Instruments
|
||
Product
Type
|
Product
Line
|
Typical
Application
|
Micromanipulators
|
PCS-6000
Micromanipulators
|
Electrophysiology
research such as patch clamp recording experiments on cells from
the brain
and central nervous system.
|
PCS-5000
Micromanipulators
|
||
Microscope
Platforms
|
Gibraltar
Platform/Stage
|
Stable
mechanical platforms that facilitate cellular research with
micropositioning and microinjection systems.
|
Microinjection
Systems
|
MIS-5000
Microinjection Manipulator
|
Microinjection
and nuclear transfer for genetics and reproductive sciences
research.
|
PiezoDrill
Inertial Impact Drill
|
||
Microelectrode
Positioner
|
LSS-8000
Inchworm System
|
Electrophysiology
research such as intracellular recording experiments
|
· |
market
study and research feasibility;
|
· |
product
definition;
|
· |
development
feasibility;
|
· |
development;
|
· |
qualification;
and
|
· |
transfer
to production.
|
· |
Production.
From production planning to product shipment, our production department
is
responsible for manufacturing high-quality products on time. Factories
are
organized in work cells; each cell consists of specialized technicians
and
equipment and has full responsibility over a product family. Technicians
are cross-trained and versatile enough, so that they can carry out
specific functions in more than one cell. This allows shorter lead
times
by alleviating bottlenecks.
|
· |
Product
Engineering and Quality.
This department, which supports our production cells, acts like a
gatekeeper to ensure the quality of our products and the effectiveness
of
our manufacturing processes. It is responsible for the transfer of
products from research and development to manufacturing, product
improvement, documentation, metrology, and the quality assurance
and
regulatory compliance process. Quality assurance represents a key
element
in our manufacturing operations. Quality is assured through product
testing at numerous stages in the manufacturing process to ensure
that our
products meet stringent industry requirements and our customers’
performance requirements. Our quality assurance program has been
certified
ISO 9001/2000 at all Telecom sites.
|
· |
Supply-Chain
Management.
This department is responsible for sales forecasting, raw material
procurement, material-cost reduction and vendor performance management.
Our products consist of optical, electronic and mechanical parts,
which
are purchased from suppliers around the world. Approximately one-third
of
our parts are manufactured to our specifications. Materials represent
the
biggest portion of our cost of goods and will continue to grow as
we rely
more and more on outsourcing our manufacturing. Our performance is
tightly
linked to vendor performance, requiring greater emphasis on this
critical
aspect of our business.
|
· |
product
performance and reliability;
|
· |
price;
|
· |
level
of technological innovation;
|
· |
product
lead times;
|
· |
breadth
of product offerings;
|
· |
ease
of use;
|
· |
brand-name
recognition;
|
· |
customer
service and technical support;
|
· |
strength
of sales and distribution relationships;
and
|
· |
financial
stability.
|
· |
a
method and apparatus for “non-intrusive” live-fiber detection and
monitoring, for which a PCT patent application has been filed. This
invention permits a fiber “clip-on” device to be attached to a cabled
fiber, essentially guaranteeing that the induced bending loss to
a
live-traffic link will never exceed 1 dB. This is a key invention
for our
new LFD-250, LFD-300, and TG-300 products, announced in September
2006,
subsequent to the end of the 2006 fiscal year.
|
· |
the
measurement of attenuation of optical fibers using bidirectional
transmission of information via the fiber for which patents were
granted
in the United States and Canada. This invention forms the basis of
our
FOT-930 and FTB-3920 products;
|
· |
a
method and apparatus for characterizing optical power levels in
three-wavelength, bidirectional fiber-to-the-home systems. This invention
describes how the optical power can be measured at the two-downstream
and
one upstream wavelengths used to connect a residence or business
customer,
while maintaining the signal continuity necessary to keep the home-based
Optical Network Terminal operating. US and PCT patent applications
have
been filed and are in process. This invention forms the basis of
the
two-port version of our PPM-350B PON Power Meter.
|
· |
an
optical spectrum analyzer using optical fibers as input and output
“slits”. This invention forms the basis of our FTB-5240, FTB-5240B and
IQ-5250 products. A patent has been granted in the US, UK, Germany,
France, and China, and an application is in process in Canada.
|
· |
a
light-curing system with closed-loop control and work-piece recording
which is at the heart of the spot-curing systems manufactured by
EXFO
Photonic Solutions and for which patents were granted in the United
States
and Canada;
|
· |
a
special optical design used in some of the X-Cite adaptors to prevent
structure in the beam from reducing the uniformity of illumination
at the
microscope objective plane, which is a key patent for our X-Cite
fluorescent illumination system. A US patent has recently been granted.
|
· |
portable
test gear for TDM and packet-based communications for which patent
applications have been filed in Canada, the United States and pursuant
to
the Patent Cooperation Treaty form the basis of the technology used
by
EXFO Protocol for a number of its protocol testing
products.
|
· |
a
method and apparatus to determine the theoretical and practical data
rates
for a cable under test. This invention forms the basis of the EXFO
CableSHARK product, describing how two test
devices, communicating with each other via the cable under
test, can predict the performance of a pair of ADSL (Asymmetric
Digital Subscriber Line) modems, and in case of problems, analyze
the
cause of the modems failing to synchronize. This patent has been
granted
in the US and in Canada.
|
Location
|
Use
of Space
|
Square
Footage
|
Type
of Interest
|
436
Nolin Street
Quebec
(Quebec)
|
Manufacturing
of telecom products
|
44,164
|
Owned
|
400
Godin Avenue
Quebec
(Quebec)
|
Research
and development, manufacturing, management and
administration
|
128,800
|
Owned
|
2260
Argentia Road
Mississauga
(Ontario)
|
Partially
occupied for research and development, manufacturing of life science
and
industrial products and administration
|
25,328
(1)
|
Leased
|
2650
Marie-Curie, St-Laurent (Quebec)
|
Research
and development, manufacturing and administration
|
26,000
|
Leased
|
160
Drumlin Circle
Concord
(Ontario)
|
Fully
occupied building for research and development, manufacturing of
EXFO’s
Copper Access Business Unit products, product management,
administration
|
23,500
|
Owned
|
Vármegye
utca 3-5 (Ausztria Ház)
Budapest,
Hungary
|
Research
and development, services (installation, training, support and
maintenance) and administration
|
2,500
|
Leased
|
Omega
Enterprise Park
Electron
Way, Chandlers Ford, Hampshire
England
|
Partially
occupied for European customer service, sales management, administration
and research and development
|
10,000
|
Leased
|
(1) |
10,672
square feet have been subleased to a third party. The total square
footage
leased is 36,000.
|
Strategic
objectives for fiscal 2007
|
Key
performance indicators for fiscal 2007
|
Increase
sales through market-share gains
|
20%
sales growth year-over-year
|
Maximize
profitability
|
7%
in earnings from operations
|
Focus
on innovation
|
35%
of sales from new products (on
the market two years or less)
|
Consolidated
statements of earnings data:
|
2006
|
2005
|
2004
|
2006
|
2005
|
2004
|
|||||||||||||
Sales
|
$
|
128,253
|
$
|
97,216
|
$
|
74,630
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
|||||||
Cost
of sales (1)
|
57,275
|
44,059
|
34,556
|
44.7
|
45.3
|
46.3
|
|||||||||||||
Gross
margin
|
70,978
|
53,157
|
40,074
|
55.3
|
54.7
|
53.7
|
|||||||||||||
Operating
expenses
|
|||||||||||||||||||
Selling
and administrative
|
40,298
|
31,782
|
25,890
|
31.4
|
32.7
|
34.7
|
|||||||||||||
Net
research and development
|
15,404
|
12,190
|
12,390
|
12.0
|
12.5
|
16.6
|
|||||||||||||
Amortization
of property, plant and equipment
|
3,523
|
4,256
|
4,935
|
2.7
|
4.4
|
6.6
|
|||||||||||||
Amortization
of intangible assets
|
4,394
|
4,836
|
5,080
|
3.4
|
5.0
|
6.8
|
|||||||||||||
Impairment
of long-lived assets
|
604
|
−
|
620
|
0.5
|
−
|
0.8
|
|||||||||||||
Government
grants
|
(1,307
|
)
|
−
|
−
|
(1.0
|
)
|
−
|
−
|
|||||||||||
Restructuring
and other charges
|
−
|
292
|
1,729
|
−
|
0.3
|
2.3
|
|||||||||||||
Total
operating expenses
|
62,916
|
53,356
|
50,644
|
49.0
|
54.9
|
67.8
|
|||||||||||||
Earnings
(loss) from operations
|
8,062
|
(199
|
)
|
(10,570
|
)
|
6.3
|
(0.2
|
)
|
(14.1
|
)
|
|||||||||
Interest
and other income
|
3,253
|
2,524
|
1,438
|
2.5
|
2.6
|
1.9
|
|||||||||||||
Foreign
exchange loss
|
(595
|
)
|
(1,336
|
)
|
(278
|
)
|
(0.5
|
)
|
(1.4
|
)
|
(0.4
|
)
|
|||||||
Earnings
(loss) before income taxes
|
10,720
|
989
|
(9,410
|
)
|
8.3
|
1.0
|
(12.6
|
)
|
|||||||||||
Income
taxes
|
2,585
|
2,623
|
(986
|
)
|
2.0
|
2.7
|
(1.3
|
)
|
|||||||||||
Net
earnings (loss) for the year
|
$
|
8,135
|
$
|
(1,634
|
)
|
$
|
(8,424
|
)
|
6.3
|
%
|
(1.7
|
)% |
(11.3
|
)% | |||||
Basic
and diluted net earnings (loss) per share
|
$
|
0.12
|
$
|
(0.02
|
)
|
$
|
(0.13
|
)
|
|||||||||||
Segment
information
|
|||||||||||||||||||
Sales:
|
|||||||||||||||||||
Telecom
Division
|
$
|
107,376
|
$
|
80,120
|
$
|
58,882
|
83.7
|
%
|
82.4
|
%
|
78.9
|
%
|
|||||||
Life
Sciences and Industrial Division
|
20,877
|
17,096
|
15,748
|
16.3
|
17.6
|
21.1
|
|||||||||||||
$
|
128,253
|
$
|
97,216
|
$
|
74,630
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
||||||||
Operating
earnings (loss):
|
|||||||||||||||||||
Telecom
Division
|
$
|
6,679
|
$
|
763
|
$
|
(5,557
|
)
|
5.2
|
%
|
0.8
|
%
|
(7.4)%
|
|||||||
Life
Sciences and Industrial Division
|
1,383
|
(962
|
)
|
(5,013
|
)
|
1.1
|
(1.0
|
)
|
(6.7
|
)
|
|||||||||
$
|
8,062
|
$
|
(199
|
)
|
$
|
(10,570
|
)
|
6.3
|
%
|
(0.2
|
)% |
(14.1
|
)% | ||||||
Research
and development data
|
|||||||||||||||||||
Gross
research and development
|
$
|
19,488
|
$
|
15,878
|
$
|
15,668
|
15.2
|
%
|
16.3
|
%
|
21.0
|
%
|
|||||||
Net
research and development
|
$
|
15,404
|
$
|
12,190
|
$
|
12,390
|
12.0
|
%
|
12.5
|
%
|
16.6
|
%
|
|||||||
Consolidated
balance sheets data:
|
|||||||||||||||||||
Total
assets
|
$
|
219,159
|
$
|
190,957
|
$
|
172,791
|
|||||||||||||
(1) The
cost of sales is exclusive of amortization, shown
separately.
|
Year
ending August 31,
|
2007
|
2008
|
2009
|
2010
|
2011
and later
|
Total
|
|||||||||||||
Long-term
debt
|
$
|
107,000
|
$
|
113,000
|
$
|
118,000
|
$
|
123,000
|
$
|
−
|
$
|
461,000
|
|||||||
Operating
leases
|
1,748,000
|
1,223,000
|
1,177,000
|
1,200,000
|
1,540,000
|
6,888,000
|
|||||||||||||
Total
commitments
|
$
|
1,855,000
|
$
|
1,336,000
|
$
|
1,295,000
|
$
|
1,323,000
|
$
|
1,540,000
|
$
|
7,349,000
|
Expiry
dates:
|
Contractual
amounts
|
Weighted
average contractual forward rates
|
|||
September
2006 to August 2007
|
$
|
37,000,000
|
1.1676
|
||
September
2007 to June 2009
|
26,800,000
|
1.1261
|
Stock
Options
|
Number
|
%
of issued and outstanding
|
Weighted
average exercise price
|
||||
Chairman
of the Board, President and CEO (one individual)
|
179,642
|
7%
|
$
|
9.05
|
|||
Board
of Directors (five individuals)
|
194,375
|
8%
|
$
|
6.23
|
|||
Management
and Corporate Officers (eight individuals)
|
313,836
|
13%
|
$
|
15.42
|
|||
687,853
|
28%
|
$
|
11.16
|
Restricted
Share Units (RSUs)
|
Number
|
%
of issued and outstanding
|
||
Chairman
of the Board, President and CEO (one individual)
|
59,913
|
14%
|
||
Management
and Corporate Officers (ten individuals)
|
255,616
|
60%
|
||
315,529
|
74%
|
Deferred
Share Units (DSUs)
|
Number
|
%
of issued and outstanding
|
||
Board
of Directors (five individuals)
|
43,290
|
100%
|
Item 6. |
Directors,
Senior Management and Employees
|
A. |
Directors
and Senior Management
|
Name
and Municipality of Residence
|
Positions
with EXFO
|
|
STEPHEN
BULL
Quebec
City, Quebec
|
Vice-President,
Research and Development, Telecom Division
|
|
NORMAND
DUROCHER
St-Sauveur,
Quebec
|
Vice-President,
Human Resources
|
|
ALLAN
FIRHOJ
Georgestown,
Ontario
|
Vice-President
and General Manager, Life Sciences and Industrial
Division
|
|
ROBERT
FITTS
Minesing,
Ontario
|
Vice-President,
Product Management - Copper Access Products
|
|
ÉTIENNE
GAGNON
Quebec
City, Quebec
|
Vice-President,
Product Management - Optical and Protocol Products
|
|
LUC
GAGNON
St-Augustin-de-Desmaures,
Quebec
|
Vice-President,
Telecom Manufacturing Operations
|
|
JUAN-FELIPE
GONZÁLEZ
Montreal,
Quebec
|
Vice-President,
Telecom Sales - International
|
|
GERMAIN
LAMONDE
Quebec
City, Quebec
|
Chairman
of the Board, President and Chief Executive Officer
|
|
PIERRE
MARCOUILLER
Magog,
Quebec
|
Independent
Director
|
|
GUY
MARIER
Lakefield
Gore, Quebec
|
Independent
Director
|
|
PIERRE
PLAMONDON, CA
Quebec
City, Quebec
|
Vice-President,
Finance and Chief Financial Officer
|
|
BENOIT
RINGUETTE
Quebec
City, Quebec
|
Corporate
Secretary and Legal Counsel
|
|
DAVID
A. THOMPSON
Newton,
North Carolina
|
Independent
Director
|
|
ANDRÉ
TREMBLAY
Outremont,
Quebec
|
Independent
Director
|
|
MICHAEL
UNGER
Richmond
Hill, Ontario
|
Independent
Lead Director
|
|
DANA
YEARIAN
Lake
Forest, Illinois
|
Vice-President,
Telecom Sales - North America
|
Annual
Retainer for Directors: (1)
|
CA$50,000
(2)
|
US$43,550
(3)
|
Annual
Retainer for Committee Chairman:
|
CA$5,000
|
US$4,355
(3)
|
Annual
Retainer for Committee Members:
|
CA$3,000
|
US$2,613
(3)
|
Fees
for all Meetings Attended per day in Person:
|
CA$1,000
|
US$871
(3)
|
Fees
for all Meetings Attended per day by Telephone:
|
CA$500
|
US$436
(3)
|
(1) |
All
the Directors elected to receive 50% of their Annual Retainer in
form of
Deferred Share Units.
|
(2) |
The
Annual Retainer for Mr. David A. Thompson is US$50,000
(CA$57,405).
|
(3) |
The
compensation information has been converted from Canadian dollars
to U.S.
dollars based upon an average foreign exchange rate of CA$1.1481
= US$1.00
for 2006.
|
Name
|
Annual
Compensation Paid in Cash (US$) (1)
|
Annual
Compensation Paid in DSUs (#) (2)
|
Estimated
Value of DSUs at the time of grant (US$) (3)
|
Total
Attendance Fees Paid in Cash (US$) (1)
|
Pierre
Marcouiller (4)
|
27,001
|
3,812
|
21,775
|
6,533
|
Guy
Marier (4)
|
27,001
|
3,812
|
21,775
|
6,968
|
David
A. Thompson (5)
|
27,613
|
4,308
|
25,000
|
3,049
|
André
Tremblay (6)
|
28,743
|
3,812
|
21,775
|
6,097
|
Michael
Unger (7)
|
28,743
|
3,812
|
21,775
|
6,533
|
(1) |
The
compensation information has been converted from Canadian dollars
to U.S.
dollars based upon an average foreign exchange rate of CA$1.1481
= US$1.00
for 2006, except for Mr. David A. Thompson who is paid in U.S. dollars
for
the portion of his annual retainer for Director. The Annual Compensation
includes, as the case may be, the retainer for Director, Committee
Members
and Committee Chairman.
|
(2) |
Indicates
the number of Subordinate Voting Shares granted under the Deferred
Share
Unit Plan. A DSU is converted in a Subordinate Voting Share when
a
Director ceases to be a member of the
Board.
|
(3) |
The
estimated value at the time of grant of a DSU is determined based
on the
highest of the closing prices of the Subordinate Voting Shares on
the
Toronto Stock Exchange and the NASDAQ National Market on the last
trading
day preceding the grant date, using the noon buying rate of the Federal
Reserve Bank of New York on the grant date to convert the NASDAQ
National
Market closing price to Canadian dollars, as required. The value
at
vesting of a DSU is equivalent to the market value of a Subordinate
Voting
Share when a DSU is converted to such Subordinate Voting
Share.
|
(4) |
Member
of the Audit Committee and the Human Resources
Committee.
|
(5) |
Member
of the Human Resources Committee.
|
(6) |
Member
of the Human Resources Committee and Chairman of the Audit
Committee.
|
(7) |
Member
of the Audit Committee, Chairman of the Human Resources Committee
and Lead
Director.
|
Name
and Principal
Position
|
Financial
Years
|
Salary
(1)
($)
|
Bonus
(2)
($)
|
Other
Annual Compensation ($)
|
Securities
Under Options (3)
(#)
|
Restricted
Share Units (4)
(#)
|
All
Other
Compensation
($)
|
Germain
Lamonde,
President
and Chief Executive Officer
|
2006
|
271,753 (US)
312,000 (CA)
|
147,558 (US)
169,412 (CA)
|
−
|
11,218
|
21,477
|
−
|
2005
|
243,605 (US)
300,000 (CA)
|
121,729 (US)
149,909 (CA)
|
−
|
17,942
|
13,089
|
−
|
|
2004
|
206,751 (US)
275,000 (CA)
|
57,115 (US)
75,969 (CA)
|
−
|
−
|
−
|
−
|
|
Pierre
Plamondon,
Vice-President
Finance and Chief Financial Officer
|
2006
|
165,691 (US)
190,230 (CA)
|
60,167 (US)
69,078 (CA)
|
−
|
3,653
|
6,994
|
4,283 (US)
(5)
4,918 (CA)
|
2005
|
151,441 (US)
186,500 (CA)
|
48,735 (US)
60,017 (CA)
|
−
|
5,383
|
33,927
|
2,316 (US)
(5)
2,852 (CA)
|
|
2004
|
135,328 (US)
180,000 (CA)
|
17,451 (US)
23,211 (CA)
|
−
|
−
|
−
|
1,429 (US)
(5)
1,901 (CA)
|
Name
and Principal
Position
|
Financial
Years
|
Salary
(1)
($)
|
Bonus
(2)
($)
|
Other
Annual Compensation ($)
|
Securities
Under Options (3)
(#)
|
Restricted
Share Units (4)
(#)
|
All
Other
Compensation
($)
|
Juan-Felipe
Gonzalez,
Vice-President
Telecom Sales - International
|
2006
|
272,518 (US)
312,878 (CA)
|
12,891 (US)
14,800 (CA)
|
−
|
3,505
|
6,716
|
−
|
2005
|
246,323 (US)
303,347 (CA)
|
6,015 (US)
7,407 (CA)
|
−
|
5,482
|
33,998
|
−
|
|
2004
|
231,597 (US)
308,047 (CA)
|
563,867 (US)
750,000 (CA)
(6)
|
−
|
−
|
−
|
−
|
|
Allan
Firhoj,
Vice-President
and General Manager, Life Sciences and Industrial Division
|
2006
|
139,361 (US)
160,000 (CA)
|
40,632 (US)
46,650 (CA)
|
−
|
2,404
|
4,602
|
−
|
2005
|
123,153 (US)
151,663 (CA)
|
18,355 (US)
22,604 (CA)
|
−
|
2,512
|
12,443
|
−
|
|
2004
|
107,796 (US)
143,379 (CA)
|
18,890 (US)
25,125 (CA)
|
−
|
−
|
−
|
−
|
|
Dana
Yearian,
Vice-President
Telecom Sales - North America
|
2006
|
173,424 (US)
(7)
199,109 (CA)
|
−
−
|
−
|
−
|
5,000
|
236 (US)
(5)
270 (CA)
|
2005
|
−
−
|
−
−
|
−
|
−
|
−
|
-
|
|
2004
|
-
-
|
-
-
|
-
|
-
|
-
|
-
|
(1) |
The
compensation information for Canadian residents has been converted
from
Canadian dollars to U.S. dollars based upon an average foreign exchange
rate of CA$1.1481 = US$1.00 for 2006, CA$1.2315 = US$1.00 for 2005
and
CA$1.3301 = US$1.00 for 2004. The currency conversions cause these
reported salaries to fluctuate from year-to-year because of the
fluctuation in exchange rate.
|
(2) |
A
portion of the bonus amounts is paid in cash in the year for which
they
are awarded and the balance is paid in cash in the year following
the
financial year for which they are
awarded.
|
(3) |
Indicates
the number of Subordinate Voting Shares underlying the options granted
under the Long-Term Incentive Plan during the financial year
indicated.
|
(4) |
Indicates
the number of Restricted Share Units granted under the Long-Term
Incentive
Plan during the financial year
indicated.
|
(5) |
Indicates
the amount contributed by the Corporation during the financial year
indicated to the Deferred Profit Sharing Plan, as applicable, for
the
benefit of the Named Executive Officer. Mr. Lamonde is not eligible
to
participate in the Deferred Profit Sharing Plan and Mr. Gonzalez did
not participate.
|
(6) |
Pursuant
to the terms of his employment agreement, Mr. Juan-Felipe Gonzalez
receive
a cash payment of CA$750,000 because he did not voluntarily resign
and was
not dismissed with cause prior to September 2003. An amount of CA$500,000
was disbursed on October 17 2003 and the remaining CA$250,000
was disbursed on January 25, 2004.
|
(7) |
This
amount represents Mr. Yearian’s annual base salary. Since Mr. Yearian
joined the Corporation on August 14, 2006, the base salary paid to
Mr.
Yearian for the financial year ended August 31, 2006 amounted to
US$7,851
(CA$9,014).
|
· |
Performance-based:
Executive compensation levels reflect both corporation and individual
results based on specific quantitative and qualitative objectives
established at the start of each financial year in keeping with our
long-term strategic objectives.
|
· |
Aligned
with shareholder interests:
A
significant proportion of incentive compensation for executives is
composed of equity awards to ensure that executives are aligned with
the
principles of sustained long-term shareholder value
growth.
|
· |
Market
competitive:
Compensation of executives is designed to be externally competitive
when
compared against executives of comparable peer companies, and in
consideration of our results relative to the results of
peers.
|
· |
Individually
equitable:
Compensation levels are also designed to reflect individual factors
such
as scope of responsibility, experience, and performance against individual
measures.
|
Measure
|
Weighting
Mr. Lamonde and Mr. Plamondon
|
Weighting
Mr. Firhoj
|
Sales
|
35%
|
30%
|
Earnings
|
15%
|
25%
|
Gross
margin
|
25%
|
25%
|
Customer
satisfaction (quality and on time delivery)
|
25%
|
20%
|
Personal
objectives (multiplier)
|
0%
- 125%
|
0%
- 125%
|
Number
of Options
|
%
of Issued and Outstanding Options
|
Weighted
Average Exercise Price ($US/Security)
|
|
President
and CEO (one individual)
|
179,642
|
7.36%
|
9.05
|
Board
of Directors (five individuals)
|
194,375
|
7.97%
|
6.23
|
Management
and Corporate Officers (eight individuals)
|
313,836
|
12.87%
|
15.42
|
Number
of RSUs
|
%
of Issued and
Outstanding
RSUs
|
Weighted
Average Fair Value at the Time of Grant
$US/RSU
|
|
President
and CEO (one individual)
|
34,566
|
10.54%
|
4.73
|
Board
of Directors (five individuals)
|
-
|
-
|
-
|
Management
and Corporate Officers (ten individuals)
|
184,161
|
56,17%
|
4.66
|
Measure
|
Weighting
ALL
|
Sales
|
35%
|
Earnings
|
15%
|
Gross
margin
|
25%
|
Customer
satisfaction (quality and on time delivery)
|
25%
|
Personal
objectives (multiplier)
|
0%
- 125%
|
Number
of DSUs
|
%
of Issued and Outstanding DSUs
|
Weighted
Average Fair Value at the Time of Grant
$US/DSU
|
|
Board
of Directors (five individuals)
|
43,290
|
100%
|
5.07
|
DSUs
#
|
Weighted
Average Fair Value at the Time of Grant US$/DSU
|
Vesting
|
19,556
|
5.81
|
At
the time Director cease to be a member of the Board of the
Corporation
|
RSUs
#
|
Fair
Value at the Time of Grant US$/RSU
|
Vesting
(1)
|
61,253
|
4.76
|
100%
on the fifth anniversary date of the grant in December 2005 subject
to
early vesting up to 1/3 on the third anniversary date of the
grant and up
to 50% of the remaining units on the fourth anniversary date
of the grant
if the performance objectives are fully attained. (2)
|
86,700
|
5.59
|
50%
on the third and fourth anniversary dates of the grant in February
2006.
(3)
|
1,500
|
6.50
|
50%
on the third and fourth anniversary dates of the grant in February
2006.
(3)
|
13,850
|
6.58
|
50%
on the third and fourth anniversary dates of the grant in February
2006.
(3)
|
3,500
|
5.90
|
50%
on the third and fourth anniversary dates of the grant in June
2006.
(4)
|
2,000
|
6.27
|
50%
on the third and fourth anniversary dates of the grant in June
2006.
(4)
|
5,000
|
5.16
|
1/3
on each of the third, fourth and fifth anniversary dates of the
grant in
August 2006 (5)
|
(1) |
All
RSUs first vesting cannot be earlier than the third anniversary
date of
their grant.
|
(2) |
Those
RSUs granted in the financial year ended August 31, 2006 vest on
the fifth
anniversary date of the grant in December 2005 but are subject
to early
vesting on the third and fourth anniversary dates of the grant
on the
attainment of performance objectives as determined by our Board
of
Directors. Accordingly, subject to the attainment of performance
objectives, the first early vesting is up to 1/3 of the units on
the third
anniversary date of the grant and the second early vesting is up
to 50% of
the remaining units on the fourth anniversary date of the
grant.
|
(3) |
Those
RSUs granted in the financial year ended August 31, 2006 vest at
a rate of
1/2 annually commencing on the third anniversary date of the grant
in
February 2006.
|
(4) |
Those
RSUs granted in the financial year ended August 31, 2006 vest at
a rate of
1/2 annually commencing on the third anniversary date of the grant
in June
2006.
|
(5) |
Those
RSUs granted in the financial year ended August 31, 2006 vest at
a rate of
1/3 annually commencing on the third anniversary date of the grant
in
August 2006.
|
Name
|
RSUs
#
|
Percentage
of Net Total of RSUs Granted to Employees in Financial
Year
(%)
|
Fair
Value at the Time of Grant US$/RSU
|
Vesting
(1)
|
Germain
Lamonde
|
21,477
|
12.36
|
4.76
|
100%
on the fifth anniversary date of the grant in December 2005 subject
to
early vesting up to 1/3 on the third anniversary date of the grant
and up
to 50% of the remaining units on the fourth anniversary date of
the grant
if the performance objectives are fully attained. (2)
|
Pierre
Plamondon
|
6,994
|
4.02
|
4.76
|
100%
on the fifth anniversary date of the grant in December 2005 subject
to
early vesting up to 1/3 on the third anniversary date of the grant
and up
to 50% of the remaining units on the fourth anniversary date of
the grant
if the performance objectives are fully attained. (2)
|
Name
|
RSUs
#
|
Percentage
of Net Total of RSUs Granted to Employees in Financial
Year
(%)
|
Fair
Value at the Time of Grant US$/RSU
|
Vesting
(1)
|
Juan-Felipe
Gonzalez
|
6,716
|
3.86
|
4.76
|
100%
on the fifth anniversary date of the grant in December 2005 subject
to
early vesting up to 1/3 on the third anniversary date of the grant
and up
to 50% of the remaining units on the fourth anniversary date of
the grant
if the performance objectives are fully attained. (2)
|
Allan
Firhoj
|
4,602
|
2.65
|
4.76
|
100%
on the fifth anniversary date of the grant in December 2005 subject
to
early vesting up to 1/3 on the third anniversary date of the grant
and up
to 50% of the remaining units on the fourth anniversary date of
the grant
if the performance objectives are fully attained. (2)
|
Dana
Yearian
|
5,000
|
2.88
|
5.16
|
1/3
on each of third, fourth and fifth anniversary dates of the grant
in
August 2006. (3)
|
(1) |
All
RSUs first vesting cannot be earlier than the third anniversary date
of
their grant.
|
(2) |
Those
RSUs granted in the financial year ended August 31, 2006 vest on
the fifth
anniversary date of the grant in December 2005 but are subject to
early
vesting on the third and fourth anniversary date of the grant on
the
attainment of performance objectives as determined by our Board of
Directors. Accordingly, subject to the attainment of performance
objectives, the first early vesting is up to 1/3 of the units on
the third
anniversary date of the grant and the second early vesting is up
to 50% of
the remaining units on the fourth anniversary date of the
grant.
|
(3) |
Those
RSUs granted in the financial year ended August 31, 2006 vest at
a rate of
1/3 annually commencing on the third anniversary date of the grant
in
August 2006.
|
Name
and Position or Office with the Corporation
|
Principal
Occupation or Employment
|
Residence
|
Director
Since
|
Germain
Lamonde
Chairman
of the Board, President and Chief Executive Officer
|
Chairman
of the Board, President and Chief Executive Officer, EXFO Electro-Optical
Engineering Inc.
|
Quebec
City, Quebec,
Canada
|
September
1985
|
Pierre
Marcouiller (1)
(2)
Independent
Director
|
Chairman
of the Board and Chief Executive Officer,
Camoplast
Inc. (a supplier of automotive and recreational vehicle
parts)
|
Magog,
Quebec,
Canada
|
May
2000
|
Guy
Marier (1)
(2)
Independent
Director
|
Executive
Consultant
|
Lakefield
Gore, Quebec,
Canada
|
January
2004
|
André
Tremblay (2)
(3)
Independent
Director
|
Founder
and Managing Partner,
Trio
Capital Inc. (a private equity fund management company)
|
Outremont,
Quebec,
Canada
|
May
2000
|
Dr.
David A. Thompson, Ph.D.
(2)
Independent
Director
|
Vice-President&
Director, Hardware & Equipment Technology Strategy, Corning Cable
Systems (involved in manufacturing innovative products for the
telecommunications industry) (5)
|
Newton,
North Carolina,
USA
|
June
2000
|
Michael
Unger (1)
(4)
Independent
Lead Director
|
Executive
Consultant
|
Richmond
Hill,
Ontario,
Canada
|
May
2000
|
(1) |
Member
of the Audit Committee.
|
(2) |
Member
of the Human Resources Committee.
|
(3) |
Chair
of the Audit Committee.
|
(4) |
Chair
of the Human Resources Committee.
|
(5) |
Corning
Incorporated is a diversified technology company that concentrate
its
efforts on high-impact growth opportunities. Corning combines its
expertise in specialty glass, ceramic materials, polymers and the
manipulation of the properties of light, with strong process and
manufacturing capabilities to develop, engineer and commercialize
significant innovative products for the telecommunications, flat
panel
display, environmental, semiconductor, and life sciences
industries.
|
Name
|
Subordinate
Voting Shares Owned
|
Currently
Exercisable Options Owned as of November 1, 2006
|
Total
Subordinate Voting Shares Beneficially Owned (3)
|
Multiple
Voting Shares Beneficially Owned (3)
|
Total
Percentage
of
Voting Power
|
||||||
In-the-money
(1)
|
Out-the-money
(2)
|
||||||||||
Number
|
Percent
|
Number
|
Percent
|
Number
|
Percent
|
Number
|
Percent
|
Number
|
Percent
|
Percent
|
|
Germain
Lamonde (4)
|
483,500
|
*
|
50,000
|
*
|
104,968
|
*
|
638,468
|
*
|
37,143,000
|
100
|
92.3
|
Pierre
Plamondon
|
35,427 (5)
|
*
|
20,000
|
*
|
54,631
|
*
|
110,058
|
*
|
−
|
−
|
*
|
Pierre
Marcouiller
|
5,000
|
*
|
21,875
|
*
|
23,882
|
*
|
50,757
|
*
|
−
|
−
|
*
|
Guy
Marier
|
1,000
|
*
|
−
|
*
|
6,250
|
*
|
7,250
|
*
|
−
|
−
|
*
|
David
A. Thompson
|
2,100
|
*
|
21,875
|
*
|
17,734
|
*
|
41,709
|
*
|
−
|
−
|
*
|
André
Tremblay
|
6,650 (6)
|
*
|
21,875
|
*
|
19,691
|
*
|
48,216
|
*
|
−
|
−
|
*
|
Michael
Unger
|
−
|
*
|
21,875
|
*
|
20,568
|
*
|
42,443
|
*
|
−
|
−
|
*
|
Name
|
Subordinate
Voting Shares Owned
|
Currently
Exercisable Options Owned as of November 1, 2006
|
Total
Subordinate Voting Shares Beneficially Owned (3)
|
Multiple
Voting Shares Beneficially Owned (3)
|
Total
Percentage
of
Voting Power
|
||||||
In-the-money
(1)
|
Out-the-money
(2)
|
||||||||||
Number
|
Percent
|
Number
|
Percent
|
Number
|
Percent
|
Number
|
Percent
|
Number
|
Percent
|
Percent
|
|
Juan-Felipe
Gonzalez
|
40,100
|
*
|
7,500
|
*
|
85,271
|
*
|
132,871
|
*
|
−
|
−
|
*
|
Allan
Firhoj
|
−
|
*
|
3,750
|
*
|
18,837
|
*
|
22,587
|
*
|
−
|
−
|
*
|
Dana
Yearian
|
−
|
*
|
−
|
*
|
−
|
*
|
−
|
*
|
−
|
−
|
*
|
Other
executive officers as a group
|
35,025
|
*
|
35,000
|
*
|
50,764
|
*
|
120,789
|
*
|
−
|
−
|
*
|
All
of our Directors and executive officers as a group
|
608,802
|
*
|
203,750
|
*
|
402,596
|
1.3
|
1,215,148
|
3.8
|
37,143,000
|
100
|
92.5
|
*
|
Less
than 1%.
|
(1)
|
“In-the-money”
options are options for which the market value of the underlying
securities is higher than the price at which such securities may
be bought
from the Corporation. As of November 1, 2006 the market value of
a
Subordinate Voting Share was
US$4.90.
|
(2)
|
“Out-the-money”
options are options for which the market value of the underlying
securities is lower than the price of which such securities may be
bought
from the Corporation.
|
(3)
|
Beneficial
ownership is determined in accordance with the rules of the SEC and
generally includes voting or investment power with respect to securities.
Options that are currently exercisable (including options that have
an
exercise price above the market price) are deemed to be outstanding
and to
be beneficially owned by the person holding such options for the
purpose
of computing the percentage ownership of such person, but are not
treated
as outstanding for the purpose of computing the percentage ownership
of
any other person. Accordingly, DSUs and RSUs are not
included.
|
(4)
|
The
number of shares held by Germain Lamonde includes 1,900,000 multiple
voting shares held of record by Fiducie Germain Lamonde, 35,243,000
multiple voting shares and 483,500 subordinate voting shares held
of
record by G. Lamonde Investissements Financiers
inc.
|
(5)
|
The
number of shares held by Pierre Plamondon includes 6,874 subordinate
voting shares held of record by Fiducie Pierre
Plamondon.
|
(6)
|
The
number of subordinate voting shares held of record by André Tremblay is
held by 9104-5559 Québec Inc, a company controlled by Mr.
Tremblay.
|
Name
|
Securities
Under Options Granted (1)
(#)
|
Exercise
Price (2)
(US$/Security)
|
Expiration
Date
|
Germain
Lamonde
|
25,402
5,080
70,000
50,000
17,942
11,218
|
$26.00
$22.25
$9.13
$1.58
$4.51
$4.76
|
June
29, 2010
January
10, 2011
October
10, 2011
September
25, 2012
February
1, 2015
December
6, 2015
|
Pierre
Plamondon
|
8,700
10,000
5,000
9,240
19,000
25,000
5,383
3,653
|
$26.00
$45.94
$34.07
$22.25
$9.13
$1.58
$5.13
$4.76
|
June
29, 2010
September
13, 2010
October
11, 2010
January
10, 2011
October
10, 2011
September
25, 2012
October
26, 2014
December
6, 2015
|
Name
|
Securities
Under Options Granted (1)
(#)
|
Exercise
Price (2)
(US$/Security)
|
Expiration
Date
|
Pierre
Marcouiller
|
2,000
400
17,966
1,037
2,479
12,500
12,500
|
$26.00
$22.25
$9.13
$12.69
$5.65
$1.58
$3.51
|
June
29, 2010
January
10, 2011
October
10, 2011
December
1, 2011
March
1, 2012
September
25, 2012
October
27, 2013
|
Guy
Marier
|
12,500
|
$4.65
|
March
24, 2014
|
David
A. Thompson
|
2,000
400
15,334
12,500
12,500
|
$26.00
$22.25
$9.13
$1.58
$3.51
|
June
29, 2010
January
10, 2011
October
10, 2011
September
25, 2012
October
27, 2013
|
André
Tremblay
|
2,000
400
17,291
12,500
12,500
|
$26.00
$22.25
$9.13
$1.58
$3.51
|
June
29, 2010
January
10, 2011
October
10, 2011
September
25, 2012
October
27, 2013
|
Michael
Unger
|
2,000
400
18,168
12,500
12,500
|
$26.00
$22.25
$9.13
$1.58
$3.51
|
June
29, 2010
January
10, 2011
October
10, 2011
September
25, 2012
October
27, 2013
|
Juan
Felipe Gonzalez
|
6,900
15,000
15,000
15,630
15,000
15,000
7,500
5,482
3,505
|
$26.00
$45.94
$34.07
$22.25
$9.13
$12.22
$1.58
$5.13
$4.76
|
June
29, 2010
September
13, 2010
October
11, 2010
January
10, 2011
October
10, 2011
January
3, 2012
September
25, 2012
October
26, 2014
December
6, 2015
|
Allan
Firhoj
|
10,000
8,000
3,750
2,512
2,404
|
$23.40
$9.13
$1.58
$5.13
$4.76
|
March
15, 2011
October
10, 2011
September
25, 2012
October
26, 2014
December
6, 2015
|
Dana
Yearian
|
−
|
−
|
−
|
Other
Executive Officers as a group
|
900
8,000
4,000
6,180
25,000
30,000
10,000
12,369
2,000
8,728
|
$26.00
$45.94
$34.07
$22.25
$9.13
$1.58
$3.19
$5.13
$4.51
$4.76
|
June
29, 2010
September
13, 2010
October
11, 2010
January
10, 2011
October
10, 2011
September
25, 2012
January
7, 2013
October
26, 2014
February
1, 2015
December
6, 2015
|
Name
|
DSUs
|
RSUs
|
||||
Number
|
Percentage
|
Estimated
Average Value at the time of grant US$/DSU (1)
|
Number
|
Percentage
|
Fair
Value at the time of grant US$/RSU (2)
|
|
Germain
Lamonde
|
−
|
−
|
−
|
13,089 (3)
|
3.1%
|
4.69
|
−
|
−
|
−
|
21,477 (4)
|
5.0%
|
4.76
|
|
−
|
−
|
−
|
25,347 (5)
|
5.9%
|
6.02
|
|
Pierre
Plamondon
|
−
|
−
|
−
|
3,927 (3)
|
1.0%
|
4.69
|
−
|
−
|
−
|
30,000 (6)
|
7.0%
|
4.69
|
|
−
|
−
|
−
|
6,994 (4)
|
1.6%
|
4.76
|
|
−
|
−
|
−
|
8,430 (5)
|
2.0%
|
6.02
|
|
−
|
−
|
−
|
4,500 (7)
|
1.1%
|
6.02
|
|
Pierre
Marcouiller
|
8,349 (8)
|
19.3%
|
5.07
|
−
|
−
|
−
|
Guy
Marier
|
8,349 (8)
|
19.3%
|
5.07
|
−
|
−
|
−
|
David
A. Thompson
|
9,894 (8)
|
22.8%
|
5.07
|
−
|
−
|
−
|
André
Tremblay
|
8,349 (8)
|
19.3%
|
5.07
|
−
|
−
|
−
|
Michael
Unger
|
8,349 (8)
|
19.3%
|
5.07
|
−
|
−
|
−
|
Juan-Felipe
Gonzalez
|
−
|
−
|
−
|
3,998 (3)
|
0.9%
|
4.69
|
−
|
−
|
−
|
30,000 (6)
|
7.0%
|
4.69
|
|
−
|
−
|
−
|
6,716 (4)
|
1.6%
|
4.76
|
|
Allan
Firhoj
|
−
|
−
|
−
|
2,443 (3)
|
0.6%
|
4.69
|
−
|
−
|
−
|
10,000 (6)
|
2.3%
|
4.69
|
|
−
|
−
|
−
|
4,602 (4)
|
1.1%
|
4.76
|
|
−
|
−
|
−
|
6,145 (5)
|
1.4%
|
6.02
|
|
Dana
Yearian
|
−
|
−
|
−
|
5,000 (9)
|
1.2%
|
5.16
|
−
|
−
|
−
|
6,645 (5)
|
1.6%
|
6.02
|
|
Other
executive officers as a group
|
−
|
−
|
−
|
9,023 (3)
|
2.1%
|
4.69
|
−
|
−
|
−
|
51,500 (6)
|
12.1%
|
4.69
|
|
−
|
−
|
−
|
16,708 (4)
|
3.9%
|
4.76
|
|
−
|
−
|
−
|
25,235 (5)
|
5.9%
|
6.02
|
|
−
|
−
|
−
|
20,500 (7)
|
4.8%
|
6.02
|
|
All
of the directors and executive officers as a group
|
−
|
−
|
−
|
32,480 (3)
|
7.6%
|
4.69
|
−
|
−
|
−
|
121,500 (6)
|
28.4%
|
4.69
|
|
−
|
−
|
−
|
56,497 (4)
|
13.2%
|
4.76
|
|
−
|
−
|
−
|
71,802 (5)
|
16.8%
|
6.02
|
|
43,290
|
100%
|
5.07
|
25,000 (7)
|
5.9%
|
6.02
|
(1) |
The
estimated average value at the time of grant of a DSU is the average
of
the estimated value at the time of grant of a DSU which is determined
based on the highest of the closing prices of the Subordinate Voting
Shares on the Toronto Stock Exchange and the NASDAQ National Market
on the
last trading day preceding the grant date, using the noon buying
rate of
the Federal Reserve Bank of New York on the grant date to convert
the
NASDAQ National Market closing price to Canadian dollars, as required.
The
value at vesting of a DSU is equivalent to the market value of a
Subordinate Voting Share when a DSU is converted to such Subordinate
Voting Share.
|
(2) |
The
fair value at the time of grant of a RSU is equal to the market value
of
Subordinate Voting Shares at the time RSUs are
granted.
|
(3) |
Those
RSUs will vest on the fifth anniversary date of the grant in January
2005
but are subject to early vesting on the third and fourth anniversary
date
of the grant on the attainment of performance objectives as determined
by
the Board of Directors. Accordingly, subject to the attainment of
performance objectives, the first early vesting is up to 1/3 of the
units
on the third anniversary date of the grant and the second early vesting
is
up to 50% of the remaining units on the fourth anniversary date of
the
grant.
|
(4) |
Those
RSUs will vest on the fifth anniversary date of the grant in December
2005
but are subject to early vesting on the third and fourth anniversary
date
of the grant on the attainment of performance objectives as determined
by
the Board of Directors. Accordingly, subject to the attainment of
performance objectives, the first early vesting is up to 1/3 of the
units
on the third anniversary date of the grant and the second early vesting
is
up to 50% of the remaining units on the fourth anniversary date of
the
grant.
|
(5) |
Those
RSUs will vest on the fifth anniversary date of the grant in October
2006
but are subject to early vesting on the third and fourth anniversary
date
of the grant on the attainment of performance objectives as determined
by
the Board of Directors. Accordingly, subject to the attainment of
performance objectives, the first early vesting is up to 1/3 of the
units
on the third anniversary date of the grant and the second early vesting
is
up to 50% of the remaining units on the fourth anniversary date of
the
grant.
|
(6) |
Those
RSUs will vest at a rate of 55%, 35% and 10%, on the third, fourth
and
fifth anniversary dates of the grant in January
2005.
|
(7) |
Those
RSUs will vest at a rate of 1/3 annually commencing on the third
anniversary date of the grant in
October 2006.
|
(8) |
Those
DSUs will vest at the time Director cease to be a member of the Board
of
the Corporation.
|
(9) |
Those
RSUs will vest at a rate of 1/3 annually commencing on the third
anniversary date of the grant in August
2006.
|
Designation
of Class
|
Number
of Securities held in escrow
|
Percentage
of Class
|
||
Subordinate
Voting Shares
|
nil
|
nil
|
||
Multiple
Voting Shares
|
nil
|
nil
|
Multiple
Voting
Shares Beneficially Owned (1)
|
Subordinate
Voting Shares Beneficially Owned (1)
|
Total
Percentage of
Voting
Power
|
||||||||||||||
Name
|
Number
|
Percent
|
Number
|
Percent
|
Percent
|
|||||||||||
Germain
Lamonde (2)
|
37,143,000
|
100
|
%
|
483,500
|
1.53
|
%
|
92.27
|
%
|
||||||||
Fiducie
Germain Lamonde (3)
|
1,900,000
|
5
|
%
|
Nil
|
Nil
|
4.71
|
%
|
|||||||||
G.
Lamonde Investissements Financiers inc. (4)
|
35,243,000
|
95
|
%
|
Nil
|
Nil
|
87.44
|
%
|
|||||||||
FMR
Corporation (5)
|
Nil
|
Nil
|
4,624,700
|
14.62
|
%
|
1.15
|
%
|
|||||||||
Kern
Capital Management, LLC (6)
|
Nil
|
Nil
|
4,596,700
|
14.53
|
%
|
1.14
|
%
|
(2) |
The
number of shares held by Germain Lamonde includes 1,900,000 multiple
voting shares held of record by Fiducie Germain Lamonde and 35,243,000
multiple voting shares and 483,500 subordinate voting shares held
of
record by G. Lamonde Investissements Financiers
inc..
|
(3) |
Fiducie
Germain Lamonde is a family trust for the benefit of Mr. Lamonde
and
members of his family.
|
(4) |
G.
Lamonde Investissements Financiers inc. is a company controlled by
Mr.
Lamonde.
|
(5) |
As
of September 30, 2006, Fidelity Management and Research Company,
a wholly
owned subsidiary of FMR Corporation, is the beneficial owner of this
number of subordinate voting shares as a result of acting as investment
advisor to various investment companies.
|
(6) |
As
of September 30, 2006, Kern Capital Management LLC controls the voting
rights attached to this number of subordinate voting shares through
relationships with several clients and does not beneficially own
directly
this number of subordinate voting
shares.
|
Location
|
Square
Footage
|
Annual
Rent
|
Expiry
Date
|
465
Godin
|
24,000
|
CA$144,000
|
November
30, 2006
|
A. |
Consolidated Statements and Other Financial
Information
|
Years
ended August 31,
|
||||||||||
2006
|
2005
|
2004
|
||||||||
Balance
- Beginning of year
|
$
|
352
|
$
|
510
|
$
|
568
|
||||
Addition
charged to earnings
|
108
|
316
|
403
|
|||||||
Write-offs
of uncollectible accounts
|
(123
|
)
|
(23
|
)
|
(48
|
)
|
||||
Recovery
of uncollectible accounts
|
(111
|
)
|
(464
|
)
|
(456
|
)
|
||||
Business
combination
|
218
|
−
|
−
|
|||||||
Foreign
currency translation adjustment
|
7
|
13
|
43
|
|||||||
Balance
- End of year
|
$
|
451
|
$
|
352
|
$
|
510
|
Years
ended August 31,
|
||||||||||
2006
|
2005
|
2004
|
||||||||
Balance
- Beginning of year
|
$
|
38,406
|
$
|
32,613
|
$
|
28,846
|
||||
Addition
(reduction) charged to earnings
|
(1,877
|
)
|
3,375
|
3,954
|
||||||
Foreign
currency translation adjustment
|
2,014
|
2,418
|
(187
|
)
|
||||||
Balance
- End of year
|
$
|
38,543
|
$
|
38,406
|
$
|
32,613
|
Years
ended August 31,
|
|||||||||||||||||||
2006
|
2005
|
2004
|
|||||||||||||||||
Export
Sales
|
$
|
119,486
|
93
|
%
|
$
|
90,386
|
92
|
%
|
$
|
68,812
|
92
|
%
|
|||||||
Domestic
Sales
|
|
8,767
|
7
|
|
6,830
|
8
|
|
5,818
|
8
|
||||||||||
$
|
128,253
|
100
|
%
|
$
|
97,216
|
100
|
%
|
$
|
74,630
|
100
|
%
|
B. |
Significant changes
|
Nasdaq
(US$)
|
TSX
(CA$)
|
||||||||||||
High
|
Low
|
High
|
Low
|
||||||||||
September
1, 2001 to August 31, 2002
|
15.00
|
1.35
|
23.80
|
2.05
|
|||||||||
September
1, 2002 to August 31, 2003
|
3.63
|
1.40
|
5.60
|
2.30
|
|||||||||
September
1, 2003 to August 31, 2004
|
7.09
|
2.71
|
9.15
|
3.75
|
|||||||||
September
1, 2004 to August 31, 2005
|
5.51
|
3.92
|
6.90
|
4.92
|
|||||||||
September
1, 2005 to August 31, 2006
|
8.69
|
4.32
|
9.60
|
5.15
|
|||||||||
2005
1st Quarter
|
5.51
|
4.27
|
6.90
|
5.73
|
|||||||||
2005
2nd Quarter
|
5.24
|
4.29
|
6.42
|
5.35
|
|||||||||
2005
3rd Quarter
|
4.99
|
3.93
|
6.05
|
4.95
|
|||||||||
2005
4th Quarter
|
5.00
|
3.92
|
6.10
|
4.92
|
|||||||||
2006
1st Quarter
|
5.05
|
4.32
|
5.92
|
5.15
|
|||||||||
2006
2nd Quarter
|
6.70
|
4.39
|
7.64
|
5.16
|
|||||||||
2006
3rd Quarter
|
8.69
|
6.44
|
9.60
|
7.18
|
|||||||||
2006
4th Quarter
|
7.01
|
4.86
|
7.80
|
5.45
|
|||||||||
2006
May
|
8.69
|
6.44
|
9.56
|
7.18
|
|||||||||
2006
June
|
7.01
|
5.21
|
7.80
|
5.81
|
|||||||||
2006
July
|
6.03
|
5.20
|
6.72
|
5.85
|
|||||||||
2006
August
|
5.66
|
4.86
|
6.30
|
5.45
|
|||||||||
2006
September
|
5.85
|
5.32
|
6.63
|
5.91
|
|||||||||
2006
October
|
6.13
|
4.93
|
6.90
|
5.55
|
|||||||||
2006
November
|
5.73
|
4.89
|
6.60
|
5.55
|
A. |
Share
Capital
|
(a)
|
an
individual citizen or resident of the United
States;
|
(b)
|
a
corporation created or organized under the laws of the United States
or
any state thereof and the District of
Columbia;
|
(c)
|
an
estate the income of which is subject to United States federal
income
taxation regardless of its source;
|
(d)
|
a
trust if (1) a court within the United States is able to exercise
primary
jurisdiction over its administration and one or more U.S. persons
have
authority to control all substantial decisions of the trust or
(2) the
trust has a valid election in effect under applicable U.S. Treasury
regulations to be treated as a U.S. person;
or
|
(e)
|
any
other person whose worldwide income or gain is otherwise subject
to U.S.
federal income taxation on a net income basis;
|
· |
the
Internal Revenue Code;
|
· |
U.S.
judicial decisions;
|
· |
administrative
pronouncements;
|
· |
existing
and proposed Treasury regulations;
and
|
· |
the
Canada - U.S. Income Tax Treaty.
|
· |
the
holder’s holding period for the subordinate voting shares, with a
preferential rate available for subordinate voting shares held
for more
than one year; and
|
· |
the
holder’s marginal tax rate for ordinary
income.
|
· |
such
gain is effectively connected with the conduct by such Non-U.S.
Holder of
a trade or business in the United States;
or
|
· |
in
the case of any gain realized by an individual Non-U.S. Holder,
such
Non-U.S. Holder is present in the United States for 183 days or more
in the taxable year of such sale and certain other conditions are
met.
|
· |
at
least 75% of our gross income for the taxable year is passive income;
or
|
· |
at
least 50% of the average value of our assets is attributable to
assets
that produce or are held for the production of passive income.
|
· |
dividends;
|
· |
interest;
|
· |
rents
or royalties, other than certain rents or royalties derived from
the
active conduct of trade or business;
|
· |
annuities;
or
|
· |
gains
from assets that produce passive income.
|
· |
any
gain realized on the sale or other disposition of subordinate voting
shares; and
|
· |
any
“excess distribution” by us to the U.S. Holder.
|
· |
the
gain or excess distribution would be allocated ratably over the
U.S.
Holder’s holding period for the subordinate voting shares;
|
· |
the
amount allocated to the taxable year in which the gain or excess
distribution was realized would be taxable as ordinary income;
|
· |
the
amount allocated to each prior year, with certain exceptions, would
be
subject to tax at the highest tax rate in effect for that year;
and
|
· |
the
interest charge generally applicable to underpayments of tax would
be
imposed in respect of the tax attributable to each such year.
|
· |
is
resident in the United States and not resident in Canada,
|
· |
holds
the subordinate voting shares as capital property,
|
· |
does
not have a “permanent establishment” or “fixed base” in Canada, as defined
in the Convention; and
|
· |
deals
at arm’s length with us. Special rules, which are not discussed below,
may
apply to “financial institutions”, as defined in the ITA, and to
non-resident insurers carrying on an insurance business in Canada
and
elsewhere.
|
Years
ending August 31,
|
||||||||||
2007
|
2008
|
2009
|
||||||||
Forward
exchange contracts to sell US dollars in exchange for Canadian
dollars
Contractual
amounts
|
$
|
37,000
|
$
|
17,800
|
$
|
9,000
|
||||
Weighted
average contractual exchange rates
|
1.1676
|
1.1388
|
1.1010
|
· |
Board
of Directors Corporate Governance
Guidelines;
|
· |
Code
of Ethics for our Principal Executive Officer and Senior Financial
Officers;
|
· |
Ethics
and Business Conduct Policy;
|
· |
Statement
of Reporting Ethical Violations (Whistle
Blower).
|
Number
|
Exhibit
|
1.1
|
Amended
Articles of Incorporation of EXFO (incorporated by reference
to Exhibit
3.1 of EXFO’s Registration Statement on Form F-1 filed on June 9, 2000,
File No. 333-38956).
|
1.2
|
Amended
By-laws of EXFO (incorporated by reference to Exhibit 1.2 of
EXFO’s annual
report on Form-20F dated January 15, 2003, File No.
000-30895).
|
1.3
|
Amended
and Restated Articles of Incorporation of EXFO (incorporated
by reference
to Exhibit 1.3 of EXFO’s annual report on Form 20-F dated January 18,
2001, File No. 000-30895).
|
2.1
|
Form
of Subordinate Voting Share Certificate (incorporated by reference
to
Exhibit 4.1 of EXFO’s Registration Statement on Form F-1 filed on June 9,
2000, File No. 333-38956).
|
2.2
|
Form
of Registration Rights Agreement between EXFO and Germain Lamonde
dated
July 6, 2000 ) (incorporated by reference to Exhibit 10.13 of
EXFO’s
Registration Statement on Form F-1 filed on June 9, 2000, File
No.
333-38956).
|
3.1
|
Form
of Trust Agreement among EXFO, Germain Lamonde, GEXFO Investissements
Technologiques inc., Fiducie Germain Lamonde and G. Lamonde
Investissements Financiers inc. (incorporated by reference to
Exhibit 4.2
of EXFO’s Registration Statement on Form F-1 filed on June 9, 2000, File
No. 333-38956).
|
4.1
|
Agreement
of Merger and Plan of Reorganization, dated as of November 4,
2000, by and
among EXFO, EXFO Sub, Inc., EXFO Burleigh Instruments, Inc.,
Robert G.
Klimasewki, William G. May, Jr., David J. Farrell and William
S. Gornall
(incorporated by reference to Exhibit 4.1 of EXFO’s annual report on Form
20-F dated January 18, 2001, File No. 000-30895).
|
4.2
|
Amendment
No. 1 to Agreement of Merger and Plan of Agreement, dated as
of December
20, 2000, by and among EXFO, EXFO Sub, Inc., EXFO Burleigh Instruments,
Inc., Robert G. Klimasewski, William G. May, Jr., David J. Farrell
and
William S. Gornall (incorporated by reference to Exhibit 4.2
of EXFO’s
annual report on Form 20-F dated January 18, 2001, File No.
000-30895).
|
4.3
|
Agreement
of Merger, dated as of August 20, 2001, by and among EXFO, Buyer
Sub, and
Avantas Networks Corporation and Shareholders of Avantas Networks
corporation (incorporated by reference to Exhibit 4.3 of EXFO’s annual
report on Form 20-F dated January 18, 2002, File No.
000-30895).
|
4.4
|
Amendment
No. 1 dated as of November 1, 2002 to Agreement of Merger, dated
as of
August 20, 2001, by and among EXFO, 3905268 Canada Inc., Avantas
Networks
Corporation and Shareholders of Avantas Networks (incorporated
by
reference to Exhibit 4.4 of EXFO’s annual report on Form 20-F dated
January 18, 2002, File No. 000-30895).
|
4.5
|
Offer
to purchase shares of Nortech Fibronic Inc., dated February 6,
2000 among
EXFO, Claude Adrien Noel, 9086-9314 Québec inc., Michel Bédard, Christine
Bergeron and Société en Commandite Capidem Québec Enr. and Certificate of
Closing, dated February 7, 2000 among the same parties (including
summary
in English) (incorporated by reference to Exhibit 10.2 of EXFO’s
Registration Statement on Form F-1 filed on June 9, 2000, File
No.
333-38956).
|
4.6
|
Share
Purchase Agreement, dated as of March 5, 2001, among EXFO Electro-Optical
Engineering, Inc., John Kennedy, Glenn Harvey and EFOS Corporation
(incorporated by reference to Exhibit 4.1 of EXFO’s Registration Statement
on Form F-3 filed on July 13, 2001, File No. 333-65122).
|
4.7
|
Amendment
Number One, dated as of March 15, 2001, to Share Purchase Agreement,
dated
as of March 5, 2001, among EXFO Electro-Optical Engineering,
Inc., John
Kennedy, Glenn Harvey and EFOS Corporation. (incorporated by
reference to
Exhibit 4.2 of EXFO’s Registration Statement on Form F-3 filed on July 13,
2001, File No. 333-65122).
|
4.8
|
Share
Purchase Agreement, dated as of November 2, 2001 between JDS
Uniphase Inc.
and 3905268 Canada Inc. (incorporated by reference to Exhibit
4.8 of
EXFO’s annual report on Form 20-F dated January 18, 2002, File No.
000-30895).
|
4.9
|
Intellectual
Property Assignment and Sale Agreement between EFOS Inc., EXFO
Electro-Optical Engineering, Inc., John Kennedy, Glenn Harvey
and EFOS
Corporation. (incorporated by reference to Exhibit 4.3 of EXFO’s
Registration Statement on Form F-3 filed on July 13, 2001, File
No.
333-65122).
|
4.10
|
Offer
to acquire a building, dated February 23, 2000, between EXFO
and Groupe
Mirabau inc. and as accepted by Groupe Mirabau inc. on February
24, 2000
(including summary in English) (incorporated by reference to
Exhibit 10.3
of EXFO’s Registration Statement on Form F-1 filed on June 9, 2000, File
No. 333-38956).
|
4.11
|
Lease
Agreement, dated December 1, 1996, between EXFO and GEXFO Investissements
Technologiques inc., as assigned to 9080-9823 Québec inc. on September 1,
1999 (including summary in English) (incorporated by reference
to Exhibit
10.4 of EXFO’s Registration Statement on Form F-1 filed on June 9, 2000,
File No. 333-38956).
|
4.12
|
Lease
Agreement, dated March 1, 1996, between EXFO and GEXFO Investissements
Technologiques inc., as assigned to 9080-9823 Québec inc. on September 1,
1999 (including summary in English) (incorporated by reference
to Exhibit
10.5 of EXFO’s Registration Statement on Form F-1 filed on June 9, 2000,
File No. 333-38956).
|
4.13
|
Lease
renewal of the existing leases between 9080-9823 Québec inc. and EXFO,
dated November 30, 2001(incorporated by reference to Exhibit
4.13 of
EXFO’s annual report on Form 20-F dated January 18, 2002, File No.
000-30895).
|
4.14
|
Loan
Agreement between EXFO and GEXFO Investissements Technologiques
inc.,
dated May 11, 1993, as assigned to 9080-9823 Québec inc. on September
1, 1999 (including summary in English) (incorporated by reference
to
Exhibit 10.9 of EXFO’s Registration Statement on Form F-1 filed on June 9,
2000, File No. 333-38956).
|
4.15
|
Resolution
of the Board of Directors of EXFO, dated September 1, 1999, authorizing
EXFO to acquire GEXFO Distribution Internationale inc. from GEXFO
Investissements Technologiques inc. (including summary in English)
(incorporated by reference to Exhibit 10.10 of EXFO’s Registration
Statement on Form F-1 filed on June 9, 2000, File No.
333-38956).
|
4.16
|
Form
of Promissory Note of EXFO issued to GEXFO Investissements Technologiques
inc. dated June 27, 2000 ) (incorporated by reference to Exhibit
10.12 of EXFO’s Registration Statement on Form F-1 filed on June 9, 2000,
File No. 333-38956).
|
4.17
|
Term
Loan Offer, dated March 28, 2000, among EXFO and National Bank
of Canada
as accepted by EXFO on April 3, 2000 (including summary in English)
(incorporated by reference to Exhibit 10.11 of EXFO’s Registration
Statement on Form F-1 filed on June 9, 2000, File No.
333-38956).
|
4.18
|
Employment
Agreement of Germain Lamonde dated May 29, 2000 (incorporated
by reference
to Exhibit 10.15 of EXFO’s Registration Statement on Form F-1 filed on
June 9, 2000, File No. 333-38956).
|
4.19
|
Employment
Agreement of Bruce Bonini dated as of September 1, 2000 (incorporated
by
reference to Exhibit 4.24 of EXFO’s annual report on Form 20-F dated
January 18, 2002, File No. 000-30895).
|
4.20
|
Employment
Agreement of Juan-Felipe Gonzalez dated as of September 1, 2000
(incorporated by reference to Exhibit 4.25 of EXFO’s annual report on Form
20-F dated January 18, 2002, File No. 000-30895).
|
4.21
|
Employment
Agreement of David J. Farrell dated as of December 20, 2000 (incorporated
by reference to Exhibit 4.26 of EXFO’s annual report on Form 20-F dated
January 18, 2002, File No. 000-30895).
|
4.22
|
Deferred
Profit Sharing Plan, dated September 1, 1998 (incorporated by
reference to
Exhibit 10.6 of EXFO’s Registration Statement on Form F-1 filed on June 9,
2000, File No. 333-38956).
|
4.23
|
Stock
Option Plan, dated May 25, 2000 (incorporated by Reference to
Exhibit 10.7
of EXFO’s Registration Statement on Form F-1 filed on June 9, 2000, File
No. 333-38956).
|
4.24
|
Share
Plan, dated April 3, 2000 (incorporated by reference to Exhibit
10.8 of
EXFO’s Registration Statement on Form F-1 filed on June 9, 2000, File
No.
333-38956).
|
4.25
|
Directors’
Compensation Plan (incorporated by reference to Exhibit 10.17
of EXFO’s
Registration Statement on Form F-1 filed on June 9, 2000, File
No.
333-38956).
|
4.26
|
Restricted
Stock Award Plan, dated December 20, 2000 (incorporated by reference
to
Exhibit 4.21 of EXFO’s annual report on Form 20-F dated January 18, 2001,
File No. 000-30895).
|
4.27
|
Asset
Purchase Agreement by
and Among EXFO Electro-Optical Engineering Inc., EXFO Gnubi Products
Group
Inc., gnubi communications, L.P., gnubi communications General
Partner,
LLC, gnubi communications Limited Partner, LLC, gnubi communications,
Inc., Voting Trust created by The Irrevocable Voting Trust Agreement
Among
Carol Abraham Bolton, Paul Abraham and James Ray Stevens, James
Ray
Stevens and Daniel J. Ernst dated September 5, 2002 (incorporated
by
reference to Exhibit 4.30 of EXFO’s annual report on Form 20-F dated
January 15, 2003, File No. 000-30895).
|
4.28
|
EXFO
Protocol Inc. Executive Employment Agreement with Sami Yazdi
signed
November 2, 2001 (incorporated by reference to Exhibit 4.28 of
EXFO’s
annual report on Form 20-F dated January 15, 2003, File No.
000-30895).
|
4.29
|
Second
Amending Agreement to the Employment Agreement of Bruce Bonini
dated as of
September 1, 2002, (incorporated by reference to Exhibit 4.29
of EXFO’s
annual report on Form 20-F dated January 15, 2004, File No.
000-30895).
|
4.30
|
Severance
and General Release Agreement with Bruce Bonini dated August
8, 2003,
(incorporated by reference to Exhibit 4.30 of EXFO’s annual report on Form
20-F dated January 15, 2004, File No. 000-30895).
|
4.31
|
Separation
Agreement and General Release with Sami Yazdi dated April 1,
2003,
(incorporated by reference to Exhibit 4.31 of EXFO’s annual report on Form
20-F dated January 15, 2004, File No. 000-30895).
|
4.32
|
Executive
Employment Agreement of James Stevens dated as of October 4,
2003,
(incorporated by reference to Exhibit 4.32 of EXFO’s annual report on Form
20-F dated January 15, 2004, File No. 000-30895).
|
4.33
|
Termination
Terms for John Holloran Jr. dated May 28, 2003, (incorporated
by reference
to Exhibit 4.33 of EXFO’s annual report on Form 20-F dated January 15,
2004, File No. 000-30895).
|
4.34
|
Employment
Agreement of Pierre Plamondon dated as of September 1, 2002,
(incorporated
by reference to Exhibit 4.34 of EXFO’s annual report on Form 20-F dated
January 15, 2004, File No. 000-30895).
|
4.35
|
Long-Term
Incentive Plan, dated May 25, 2000, amended in October 2004 and
effective
January 12, 2005 (incorporated by reference to Exhibit 4.35 of
EXFO’s
annual report on Form 20-F dated November 29, 2005, File No.
000-30895).
|
4.36
|
Deferred
Share Unit Plan, effective January 12, 2005 (incorporated by
reference to
Exhibit 4.36 of EXFO’s annual report on Form 20-F dated November 29, 2005,
File No. 000-30895).
|
4.37
|
Asset
Purchase Agreement by and Among EXFO Electro-Optical Engineering
Inc.,
Consultronics Limited., Andre Rekai, Consultronics Europe Limited,
Consultronics Development Kft. and Consultronics Inc. dated January
5,
2006.
|
8.1
|
Subsidiaries
of EXFO (list included in Item 4C of this annual report).
|
11.1
|
Code
of Ethics for senior financial officers, (incorporated by reference
to
Exhibit 11.1 of EXFO’s annual report on Form 20-F dated January 15, 2004,
File No. 000-30895).
|
11.2
|
Board
of Directors Corporate Governance Guidelines (incorporated by
reference to
Exhibit 11.2 of EXFO’s annual report on Form 20-F dated November 29, 2005,
File No. 000-30895).
|
11.3
|
Code
of Ethics for our Principal Executive Officer and Senior Financial
Officers (incorporated by reference to Exhibit 11.3 of EXFO’s annual
report on Form 20-F dated November 29, 2005, File No.
000-30895).
|
11.4
|
Ethics
and Business Conduct Policy (incorporated by reference to Exhibit
11.4 of
EXFO’s annual report on Form 20-F dated November 29, 2005, File No.
000-30895).
|
11.5
|
Statement
of Reporting Ethical Violations (Whistle Blower) (incorporated
by
reference to Exhibit 11.5 of EXFO’s annual report on Form 20-F dated
November 29, 2005, File No. 000-30895).
|
11.6
|
Audit
Committee Charter (incorporated by reference to Exhibit 11.6
of EXFO’s
annual report on Form 20-F dated November 29, 2005, File No.
000-30895).
|
11.7
|
Human
Resources Committee Charter (incorporated by reference to Exhibit
11.7 of
EXFO’s annual report on Form 20-F dated November 29, 2005, File No.
000-30895).
|
12.1
|
Certification
of the Chief Executive Officer Pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
12.2
|
Certification
of the Chief Executive Officer Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
|
13.1
|
Certification
of the Chief Financial Officer Pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
13.2
|
Certification
of the Chief Financial Officer Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
|
As
at August 31,
|
|||||||
2006
|
2005
|
||||||
Assets
|
|||||||
Current
assets
|
|||||||
Cash
|
$
|
6,853
|
$
|
7,119
|
|||
Short-term
investments (notes 8 and 18)
|
104,437
|
104,883
|
|||||
Accounts
receivable (notes 8 and 18)
|
|||||||
Trade
|
20,891
|
13,945
|
|||||
Other
(note 4)
|
2,792
|
2,007
|
|||||
Income
taxes and tax credits recoverable (note 8)
|
2,201
|
2,392
|
|||||
Inventories
(notes 5 and 8)
|
24,623
|
17,749
|
|||||
Prepaid
expenses
|
1,404
|
1,112
|
|||||
163,201
|
149,207
|
||||||
Income
taxes recoverable
|
476
|
459
|
|||||
Property,
plant and equipment (notes
4, 6 and 8)
|
17,392
|
13,719
|
|||||
Long-lived
asset held for sale (note
4)
|
−
|
1,600
|
|||||
Intangible
assets (notes
7 and 8)
|
10,948
|
5,602
|
|||||
Goodwill
(note
7)
|
27,142
|
20,370
|
|||||
$
|
219,159
|
$
|
190,957
|
||||
Liabilities
|
|||||||
Current
liabilities
|
|||||||
Accounts
payable and accrued liabilities (note 9)
|
$
|
17,337
|
$
|
12,201
|
|||
Deferred
revenue
|
1,772
|
1,584
|
|||||
Current
portion of long-term debt
|
107
|
134
|
|||||
19,216
|
13,919
|
||||||
Deferred
revenue
|
2,632
|
1,568
|
|||||
Government
grants (note
15)
|
723
|
1,872
|
|||||
Long-term
debt (note
10)
|
354
|
198
|
|||||
22,925
|
17,557
|
||||||
Commitments
(note 11)
|
|||||||
Contingencies
(note 12)
|
|||||||
Shareholders’
Equity
|
|||||||
Share
capital (note 13)
|
148,921
|
521,875
|
|||||
Contributed
surplus
|
3,776
|
2,949
|
|||||
Deficit
(note 13)
|
−
|
(381,846
|
)
|
||||
Cumulative
translation adjustment
|
43,537
|
30,422
|
|||||
196,234
|
173,400
|
||||||
$
|
219,159
|
$
|
190,957
|
Years
ended August 31,
|
||||||||||
2006
|
2005
|
2004
|
||||||||
Sales
(note 19)
|
$
|
128,253
|
$
|
97,216
|
$
|
74,630
|
||||
Cost
of sales (1,2)
|
57,275
|
44,059
|
34,556
|
|||||||
Gross
margin
|
70,978
|
53,157
|
40,074
|
|||||||
Operating
expenses
|
||||||||||
Selling
and administrative (1)
|
40,298
|
31,782
|
25,890
|
|||||||
Net
research and development (1)
(note
15)
|
15,404
|
12,190
|
12,390
|
|||||||
Amortization
of property, plant and equipment
|
3,523
|
4,256
|
4,935
|
|||||||
Amortization
of intangible assets
|
4,394
|
4,836
|
5,080
|
|||||||
Impairment
of long-lived assets (note 4)
|
604
|
−
|
620
|
|||||||
Government
grants (note 15)
|
(1,307
|
)
|
−
|
−
|
||||||
Restructuring
and other charges (note 4)
|
−
|
292
|
1,729
|
|||||||
Total
operating expenses
|
62,916
|
53,356
|
50,644
|
|||||||
Earnings
(loss) from operations
|
8,062
|
(199
|
)
|
(10,570
|
)
|
|||||
Interest
and other income
|
3,253
|
2,524
|
1,438
|
|||||||
Foreign
exchange loss
|
(595
|
)
|
(1,336
|
)
|
(278
|
)
|
||||
Earnings
(loss) before income taxes (note
16)
|
10,720
|
989
|
(9,410
|
)
|
||||||
Income
taxes (note
16)
|
2,585
|
2,623
|
(986
|
)
|
||||||
Net
earnings (loss) for the year
|
$
|
8,135
|
$
|
(1,634
|
)
|
$
|
(8,424
|
)
|
||
Basic
and diluted net earnings (loss) per share
|
$
|
0.12
|
$
|
(0.02
|
)
|
$
|
(0.13
|
)
|
||
Basic
weighted average number of shares outstanding
(000’s)
|
68,643
|
68,526
|
66,020
|
|||||||
Diluted
weighted average number of
shares
outstanding (000’s) (note
17)
|
69,275
|
68,981
|
66,615
|
|||||||
(1) Stock-based
compensation costs included in:
|
||||||||||
Cost
of sales
|
$
|
127
|
$
|
143
|
$
|
62
|
||||
Selling
and administrative
|
701
|
626
|
265
|
|||||||
Net
research and development
|
204
|
194
|
122
|
|||||||
$
|
1,032
|
$
|
963
|
$
|
449
|
|||||
(2) The
cost of sales is exclusive of amortization, shown separately.
|
Deficit
|
||||||||||
Years
ended August 31,
|
||||||||||
2006
|
2005
|
2004
|
||||||||
Balance
- Beginning of year
|
$
|
(381,846
|
)
|
$
|
(380,212
|
)
|
$
|
(371,788
|
)
|
|
Deduct
(add)
|
||||||||||
Net
earnings (loss) for the year
|
8,135
|
(1,634
|
)
|
(8,424
|
)
|
|||||
Elimination
of deficit by reduction of share capital (note 13)
|
373,711
|
−
|
−
|
|||||||
Balance
- End of year
|
$
|
−
|
$
|
(381,846
|
)
|
$
|
(380,212
|
)
|
Contributed
surplus
|
||||||||||
Years
ended August 31,
|
||||||||||
2006
|
2005
|
2004
|
||||||||
Balance
- Beginning of year
|
$
|
2,949
|
$
|
1,986
|
$
|
1,519
|
||||
Add
(deduct)
|
||||||||||
Stock-based
compensation costs
|
1,027
|
963
|
449
|
|||||||
Reclassification
of stock-based compensation costs to share capital upon exercise
of stock
awards (note 13)
|
(200
|
)
|
−
|
−
|
||||||
Premium
on resale of share capital
|
−
|
−
|
18
|
|||||||
Balance
- End of year
|
$
|
3,776
|
$
|
2,949
|
$
|
1,986
|
Years
ended August 31,
|
||||||||||
2006
|
2005
|
2004
|
||||||||
Cash
flows from operating activities
|
||||||||||
Net
earnings (loss) for the year
|
$
|
8,135
|
$
|
(1,634
|
)
|
$
|
(8,424
|
)
|
||
Add
(deduct) items not affecting cash
|
||||||||||
Discount
on short-term investments
|
(229
|
)
|
(302
|
)
|
197
|
|||||
Stock-based
compensation costs
|
1,032
|
963
|
449
|
|||||||
Amortization
|
7,917
|
9,092
|
10,015
|
|||||||
Impairment
of long-lived assets
|
604
|
−
|
620
|
|||||||
Restructuring
and other charges
|
−
|
−
|
1,261
|
|||||||
Government
grants
|
(1,307
|
)
|
−
|
154
|
||||||
Deferred
revenue
|
786
|
977
|
1,404
|
|||||||
16,938
|
9,096
|
5,676
|
||||||||
Change
in non-cash operating items
|
||||||||||
Accounts
receivable
|
(2,637
|
)
|
(838
|
)
|
(2,677
|
)
|
||||
Income
taxes and tax credits
|
329
|
6,096
|
(2,464
|
)
|
||||||
Inventories
|
(2,287
|
)
|
(699
|
)
|
1,016
|
|||||
Prepaid
expenses
|
79
|
544
|
(449
|
)
|
||||||
Accounts
payable and accrued liabilities
|
(144
|
)
|
(164
|
)
|
(351
|
)
|
||||
12,278
|
14,035
|
751
|
||||||||
Cash
flows from investing activities
|
||||||||||
Additions
to short-term investments
|
(673,289
|
)
|
(585,665
|
)
|
(653,348
|
)
|
||||
Proceeds
from disposal and maturity of short-term investments
|
681,500
|
574,207
|
624,722
|
|||||||
Additions
to property, plant and equipment and intangible assets
|
(3,378
|
)
|
(1,501
|
)
|
(851
|
)
|
||||
Business
combinations, net of cash acquired
|
(18,054
|
)
|
−
|
(241
|
)
|
|||||
(13,221
|
)
|
(12,959
|
)
|
(29,718
|
)
|
|||||
Cash
flows from financing activities
|
||||||||||
Repayment
of long-term debt
|
(415
|
)
|
(121
|
)
|
(109
|
)
|
||||
Net
proceeds of offering (note 13)
|
−
|
−
|
29,164
|
|||||||
Exercise
of stock options
|
557
|
148
|
254
|
|||||||
Share
issue expenses
|
−
|
(6
|
)
|
(137
|
)
|
|||||
Redemption
of share capital
|
−
|
−
|
(5
|
)
|
||||||
Resale
of share capital
|
−
|
−
|
23
|
|||||||
142
|
21
|
29,190
|
||||||||
Effect
of foreign exchange rate changes on cash
|
535
|
863
|
(430
|
)
|
||||||
Change
in cash
|
(266
|
)
|
1,960
|
(207
|
)
|
|||||
Cash
- Beginning of year
|
7,119
|
5,159
|
5,366
|
|||||||
Cash
- End of year
|
$
|
6,853
|
$
|
7,119
|
$
|
5,159
|
||||
Supplementary
information
|
||||||||||
Interest
paid
|
$
|
65
|
$
|
30
|
$
|
408
|
||||
Income
taxes paid (recovered)
|
$
|
2,541
|
$
|
(669
|
)
|
$
|
120
|
Term
|
||
Land
improvements
|
5
years
|
|
Buildings
|
25
years
|
|
Equipment
|
2
to 10 years
|
|
Leasehold
improvements
|
The
lesser of useful life and remaining lease
term
|
Assets
acquired
|
||||
Current
assets
|
$
|
5,135
|
||
Property,
plant and equipment
|
3,115
|
|||
Core
technology
|
8,709
|
|||
Current
liabilities assumed
|
(2,826
|
)
|
||
Loans
assumed
|
(402
|
)
|
||
Net
identifiable assets acquired
|
13,731
|
|||
Goodwill
|
5,107
|
|||
Purchase
price, net of cash acquired
|
$
|
18,838
|
Balance
as at
August
31,
2005
|
Additions
|
Payments
|
Adjustments
|
Balance
as at
August
31,
2006
|
||||||||||||
Fiscal
2006 plan (note 3)
|
||||||||||||||||
Severance
expenses
|
$
|
−
|
$
|
660
|
$
|
(29
|
)
|
$
|
−
|
$
|
631
|
|||||
Fiscal
2003 plan
|
||||||||||||||||
Exited
leased facilities
|
150
|
−
|
(90
|
)
|
−
|
60
|
||||||||||
Total
for all plans (note 9)
|
$
|
150
|
$
|
660
|
$
|
(119
|
)
|
$
|
−
|
$
|
691
|
Balance
as at
August
31,
2004
|
Additions
|
Payments
|
Adjustments
|
Balance
as at
August
31,
2005
|
||||||||||||
Fiscal
2004 plan
|
||||||||||||||||
Severance
expenses
|
$
|
467
|
$
|
83
|
$
|
(550
|
)
|
$
|
−
|
$
|
−
|
|||||
Other
|
$
|
−
|
$
|
399
|
$
|
(399
|
)
|
$
|
−
|
$
|
−
|
|||||
467
|
482
|
(949
|
)
|
−
|
−
|
|||||||||||
Fiscal
2003 plan
|
||||||||||||||||
Severance
expenses
|
109
|
−
|
(77
|
)
|
(32
|
)
|
−
|
|||||||||
Exited
leased facilities
|
386
|
−
|
(229
|
)
|
(7
|
)
|
150
|
|||||||||
Other
|
197
|
−
|
(46
|
)
|
(151
|
)
|
−
|
|||||||||
692
|
−
|
(352
|
)
|
(190
|
)
|
150
|
||||||||||
Fiscal
2001 plan
|
||||||||||||||||
Exited
leased facilities
|
10
|
−
|
(10
|
)
|
−
|
−
|
||||||||||
Total
for all plans (note 9)
|
$
|
1,169
|
$
|
482
|
$
|
(1,311
|
)
|
$
|
(190
|
)
|
$
|
150
|
Balance
as at
August
31,
2003
|
Additions
|
Payments
|
Adjustments
|
Balance
as at
August
31,
2004
|
||||||||||||
Fiscal
2004 plan
|
||||||||||||||||
Severance
expenses
|
$
|
−
|
$
|
772
|
$
|
(305
|
)
|
$
|
−
|
$
|
467
|
|||||
Fiscal
2003 plan
|
||||||||||||||||
Severance
expenses
|
1,233
|
−
|
(870
|
)
|
(254
|
)
|
109
|
|||||||||
Exited
leased facilities
|
748
|
−
|
(362
|
)
|
−
|
386
|
||||||||||
Other
|
295
|
−
|
(90
|
)
|
(8
|
)
|
197
|
|||||||||
2,276
|
−
|
(1,322
|
)
|
(262
|
)
|
692
|
||||||||||
Fiscal
2002 plans
|
||||||||||||||||
Other
|
68
|
−
|
(68
|
)
|
−
|
−
|
||||||||||
Fiscal
2001 plan
|
||||||||||||||||
Exited
leased facilities
|
124
|
−
|
(72
|
)
|
(42
|
)
|
10
|
|||||||||
Total
for all plans
|
$
|
2,468
|
$
|
772
|
$
|
(1,767
|
)
|
$
|
(304
|
)
|
$
|
1,169
|
As
at August 31,
|
|||||||
2006
|
2005
|
||||||
Raw
materials
|
$
|
14,353
|
$
|
9,373
|
|||
Work
in progress
|
1,043
|
934
|
|||||
Finished
goods
|
9,227
|
7,442
|
|||||
$
|
24,623
|
$
|
17,749
|
As
at August 31,
|
|||||||||||||
2006
|
2005
|
||||||||||||
|
Cost
|
Accumulated
amortization
|
Cost
|
Accumulated
amortization
|
|||||||||
Land
and land improvements
|
$
|
4,249
|
$
|
1,082
|
$
|
3,179
|
$
|
815
|
|||||
Buildings
|
14,417
|
6,262
|
9,206
|
2,250
|
|||||||||
Equipment
|
33,562
|
28,263
|
33,216
|
29,553
|
|||||||||
Leasehold
improvements
|
2,788
|
2,017
|
2,395
|
1,659
|
|||||||||
55,016
|
$
|
37,624
|
47,996
|
$
|
34,277
|
||||||||
Less:
|
|||||||||||||
Accumulated
amortization
|
37,624
|
34,277
|
|||||||||||
$
|
17,392
|
$
|
13,719
|
As
at August 31,
|
|||||||||||||
2006
|
2005
|
||||||||||||
|
Cost
|
Accumulated
amortization
|
Cost
|
Accumulated
amortization
|
|||||||||
Core
technology
|
$
|
47,629
|
$
|
38,972
|
$
|
35,554
|
$
|
32,214
|
|||||
Software
|
6,781
|
4,490
|
6,607
|
4,345
|
|||||||||
54,410
|
$
|
43,462
|
42,161
|
$
|
36,559
|
||||||||
Less:
|
|||||||||||||
Accumulated
amortization
|
43,462
|
36,559
|
|||||||||||
$
|
10,948
|
$
|
5,602
|
As
at August 31,
|
|||||||
2006
|
2005
|
||||||
Balance
- Beginning of year
|
$
|
20,370
|
$
|
18,393
|
|||
Addition
from business combination (note 3)
|
5,107
|
−
|
|||||
Foreign
currency translation adjustment
|
1,665
|
1,977
|
|||||
Balance
- End of year (note 19)
|
$
|
27,142
|
$
|
20,370
|
As
at August 31,
|
|||||||
2006
|
2005
|
||||||
Trade
|
$
|
7,487
|
$
|
5,781
|
|||
Salaries
and social benefits
|
5,991
|
4,526
|
|||||
Warranty
|
1,006
|
725
|
|||||
Commissions
|
835
|
211
|
|||||
Restructuring
charges (note 4)
|
691
|
150
|
|||||
Business
combination (note 3)
|
185
|
−
|
|||||
Other
|
1,142
|
808
|
|||||
$
|
17,337
|
$
|
12,201
|
As
at August 31,
|
|||||||
2006
|
2005
|
||||||
Balance
- Beginning of year
|
$
|
725
|
$
|
390
|
|||
Provision
|
895
|
869
|
|||||
Settlements
|
(708
|
)
|
(583
|
)
|
|||
Addition
from business combination
|
31
|
−
|
|||||
Foreign
currency translation adjustment
|
63
|
49
|
|||||
Balance
- End of year
|
$
|
1,006
|
$
|
725
|
As
at August 31,
|
|||||||
2006
|
2005
|
||||||
Loans
collateralized by equipment, bearing interest at 4.9%, repayable
in
monthly installments of $10,600 including principal and interest,
maturing
in 2010
|
$
|
461
|
$
|
−
|
|||
Loans
collateralized by equipment, bearing interest at 9.6%, fully repaid
in
fiscal 2006
|
−
|
332
|
|||||
461
|
332
|
||||||
Less:
Current portion
|
107
|
134
|
|||||
$
|
354
|
$
|
198
|
Multiple
voting shares
|
Subordinate
voting shares
|
|||||||||||||||
Number
|
Amount
|
Number
|
Amount
|
Total
amount
|
||||||||||||
Balance
as at August 31, 2003
|
37,900,000
|
$
|
1
|
25,139,908
|
$
|
492,451
|
$
|
492,452
|
||||||||
Public
offering (1)
|
−
|
−
|
5,200,000
|
29,164
|
29,164
|
|||||||||||
Exercise
of stock options (note 14)
|
−
|
−
|
111,071
|
254
|
254
|
|||||||||||
Exercise
of restricted stock awards (note 14)
|
−
|
−
|
89,504
|
−
|
−
|
|||||||||||
Redemption
|
−
|
−
|
(5,340
|
)
|
(5
|
)
|
(5
|
)
|
||||||||
Resale
|
−
|
−
|
5,340
|
5
|
5
|
|||||||||||
Share
issue expenses
|
−
|
−
|
−
|
(137
|
)
|
(137
|
)
|
|||||||||
Balance
as at August 31, 2004
|
37,900,000
|
1
|
30,540,483
|
521,732
|
521,733
|
|||||||||||
Exercise
of stock options (note 14)
|
−
|
−
|
71,699
|
148
|
148
|
|||||||||||
Exercise
of restricted stock awards (note 14)
|
−
|
−
|
53,592
|
−
|
−
|
|||||||||||
Share
issue expenses
|
−
|
−
|
−
|
(6
|
)
|
(6
|
)
|
|||||||||
Balance
as at August 31, 2005
|
37,900,000
|
1
|
30,665,774
|
521,874
|
521,875
|
|||||||||||
Exercise
of stock options (note 14)
|
−
|
−
|
182,425
|
557
|
557
|
|||||||||||
Exercise
of restricted share units (note 14)
|
−
|
−
|
4,770
|
−
|
−
|
|||||||||||
Conversion
of multiple voting shares into subordinate voting shares
|
(757,000
|
)
|
−
|
757,000
|
−
|
−
|
||||||||||
Reclassification
of stock-based compensation cost to share capital upon exercise
of stock
awards
|
−
|
−
|
−
|
200
|
200
|
|||||||||||
Elimination
of deficit by reduction of share capital (2)
|
−
|
−
|
−
|
(373,711
|
)
|
(373,711
|
)
|
|||||||||
Balance
as at August 31, 2006
|
37,143,000
|
$
|
1
|
31,609,969
|
$
|
148,920
|
$
|
148,921
|
(1) |
On
February 12, 2004, pursuant to a Canadian public offering, the
company
issued 5,200,000 subordinate voting shares for net proceeds of
$29,164,000
(CA$38,438,400), after deduction of underwriting commission of
$1,215,000
(CA$1,601,000).
|
(2) |
Upon
the approval of the Board of Directors dated August 31, 2006, the
company
eliminated its deficit against its share
capital.
|
Years
ended August 31,
|
|||||||||||||||||||
2006
|
2005
|
2004
|
|||||||||||||||||
Number
|
Weighted
average exercise price
|
Number
|
Weighted
average exercise price
|
Number
|
Weighted
average exercise price
|
||||||||||||||
(CA$)
|
(CA$)
|
(CA$)
|
|||||||||||||||||
Outstanding
- Beginning of year
|
2,763,759
|
$
|
19
|
2,934,518
|
$
|
21
|
3,176,613
|
$
|
23
|
||||||||||
Granted
|
31,992
|
6
|
246,233
|
6
|
536,500
|
5
|
|||||||||||||
Exercised
|
(182,425
|
)
|
(4
|
)
|
(71,699
|
)
|
(3
|
)
|
(111,071
|
)
|
(3
|
)
|
|||||||
Forfeited
|
(173,951
|
)
|
(18
|
)
|
(345,293
|
)
|
(27
|
)
|
(667,524
|
)
|
(23
|
)
|
|||||||
Outstanding
- End of year
|
2,439,375
|
$
|
20
|
2,763,759
|
$
|
19
|
2,934,518
|
$
|
21
|
||||||||||
Exercisable
- End of year
|
1,852,870
|
$
|
25
|
1,650,404
|
$
|
28
|
1,331,707
|
$
|
32
|
Years
ended August 31,
|
||||||
2006
|
2005
|
2004
|
||||
Risk-free
interest rate
|
3.9%
|
3.6%
|
2.7%
|
|||
Expected
volatility (based on historical volatility)
|
87%
|
95%
|
100%
|
|||
Dividend
yield
|
Nil
|
Nil
|
Nil
|
|||
Expected
life
|
66
months
|
66
months
|
49
months
|
Stock
options outstanding
|
Stock
options exercisable
|
|||||||||||||||||||||
Exercise
price
|
Number
|
Weighted
average
exercise
price
|
Aggregate
intrinsic value
|
|
Weighted
average
remaining
contractual
life
|
Number
|
Weighted
average
exercise
price
|
Aggregate
intrinsic value
|
|
|||||||||||||
(CA$)
|
(CA$
|
)
|
(CA$
|
) |
(CA$
|
)
|
(CA$ | ) | ||||||||||||||
$2.50
to $3.36
|
419,655
|
$
|
2.50
|
$
|
1,402
|
6.1
years
|
273,313
|
$
|
2.50
|
$
|
913
|
|||||||||||
$3.96
to $5.84
|
547,687
|
5.07
|
422
|
7.6
years
|
206,464
|
4.92
|
190
|
|||||||||||||||
$6.22
to $9.02
|
193,200
|
6.52
|
−
|
7.4
years
|
94,260
|
6.82
|
−
|
|||||||||||||||
$14.27
to $20.00
|
476,396
|
15.78
|
−
|
5.2
years
|
476,396
|
15.78
|
−
|
|||||||||||||||
$29.70
to $43.00
|
564,436
|
36.27
|
−
|
4.2
years
|
564,436
|
36.27
|
−
|
|||||||||||||||
$51.25
to $68.17
|
199,771
|
65.76
|
−
|
4.0
years
|
199,771
|
65.76
|
−
|
|||||||||||||||
$83.66
|
38,230
|
83.66
|
−
|
4.0
years
|
38,230
|
83.66
|
−
|
|||||||||||||||
2,439,375
|
$
|
20.26
|
$
|
1,824
|
5.7
years
|
1,852,870
|
$
|
25.19
|
$
|
1,103
|
Years
ended August 31,
|
|||||||
2006
|
2005
|
||||||
Outstanding
- Beginning of year
|
176,185
|
−
|
|||||
Granted
|
173,803
|
176,185
|
|||||
Exercised
|
(4,770
|
)
|
−
|
||||
Forfeited
|
(17,341
|
)
|
−
|
||||
Outstanding
- End of year
|
327,877
|
176,185
|
Years
ended August 31,
|
|||||||
2006
|
2005
|
||||||
Outstanding
- Beginning of year
|
23,734
|
−
|
|||||
Granted
|
19,556
|
23,734
|
|||||
Outstanding
- End of year
|
43,290
|
23,734
|
Years
ended August 31,
|
|||||||||||||||||||
2006
|
2005
|
2004
|
|||||||||||||||||
|
Number |
Weighted
average
exercise
price
|
Number
|
Weighted
average
exercise
price
|
Number
|
Weighted
average
exercise
price
|
|||||||||||||
Outstanding
- Beginning of year
|
19,000
|
$
|
12
|
13,000
|
$
|
16
|
9,000
|
$
|
24
|
||||||||||
Granted
|
5,500
|
6
|
6,000
|
4
|
6,000
|
5
|
|||||||||||||
Forfeited
|
−
|
−
|
−
|
−
|
(2,000
|
)
|
(19
|
)
|
|||||||||||
Outstanding
- End of year
|
24,500
|
$
|
11
|
19,000
|
$
|
12
|
13,000
|
$
|
16
|
||||||||||
Exercisable
- End of year
|
11,000
|
$
|
18
|
7,500
|
$
|
24
|
4,250
|
$
|
30
|
Stock
appreciation
rights
outstanding
|
Stock
appreciation rights exercisable
|
|||||||||
Exercise
price
|
Number
|
Weighted
average remaining contractual life
|
Number
|
|||||||
$2.21
|
2,000
|
6.6
years
|
1,500
|
|||||||
$4.51
to $6.50
|
17,500
|
8.4
years
|
4,500
|
|||||||
$22.25
|
2,500
|
4.4
years
|
2,500
|
|||||||
$45.94
|
2,500
|
4.0
years
|
2,500
|
|||||||
24,500
|
7.4
years
|
11,000
|
Years
ended August 31,
|
|||||||
2005
|
2004
|
||||||
Outstanding
- Beginning of year
|
53,592
|
143,096
|
|||||
Exercised
|
(53,592
|
)
|
(89,504
|
)
|
|||
Outstanding
- End of year
|
−
|
53,592
|
Years
ended August 31,
|
||||||||||
2006
|
2005
|
2004
|
||||||||
Gross
research and development expenses
|
$
|
19,488
|
$
|
15,878
|
$
|
15,668
|
||||
Research
and development tax credits and grants
|
(4,084
|
)
|
(3,688
|
)
|
(3,278
|
)
|
||||
$
|
15,404
|
$
|
12,190
|
$
|
12,390
|
· |
Deferred
profit-sharing plan
|
· |
401K
plan
|
Years
ended August 31,
|
||||||||||
2006
|
2005
|
2004
|
||||||||
Income
tax provision at combined Canadian federal and provincial statutory
tax
rate (32% in 2006, 31% in 2005 and 32% in 2004)
|
$
|
3,430
|
$
|
307
|
$
|
(3,011
|
)
|
|||
Increase
(decrease) due to:
|
||||||||||
Foreign
income taxed at different rates
|
(85
|
)
|
(580
|
)
|
(767
|
)
|
||||
Non-taxable
income
|
(207
|
)
|
(827
|
)
|
(128
|
)
|
||||
Non-deductible
expenses
|
527
|
784
|
1,205
|
|||||||
Tax
deductions
|
−
|
(81
|
)
|
(169
|
)
|
|||||
Change
in enacted rates
|
497
|
−
|
274
|
|||||||
Effect
of consolidation of subsidiaries
|
61
|
(209
|
)
|
(1,384
|
)
|
|||||
Previous
year tax recovery
|
−
|
−
|
(1,406
|
)
|
||||||
Other
|
239
|
(146
|
)
|
446
|
||||||
Change
in valuation allowance
|
(1,877
|
)
|
3,375
|
3,954
|
||||||
$
|
2,585
|
$
|
2,623
|
$
|
(986
|
)
|
||||
The
income tax provision consists of the following:
|
||||||||||
Current
|
||||||||||
Canadian
|
$
|
2,573
|
$
|
2,513
|
$
|
(577
|
)
|
|||
Other
|
12
|
110
|
(409
|
)
|
||||||
2,585
|
2,623
|
(986
|
)
|
|||||||
Future
|
||||||||||
Canadian
|
2,687
|
(1,445
|
)
|
(1,104
|
)
|
|||||
United
States
|
(601
|
)
|
(1,723
|
)
|
(2,448
|
)
|
||||
Other
|
(209
|
)
|
(207
|
)
|
(402
|
)
|
||||
1,877
|
(3,375
|
)
|
(3,954
|
)
|
||||||
Valuation
allowance
|
||||||||||
Canadian
|
(2,687
|
)
|
1,445
|
1,104
|
||||||
United
States
|
601
|
1,723
|
2,448
|
|||||||
Other
|
209
|
207
|
402
|
|||||||
(1,877
|
)
|
3,375
|
3,954
|
|||||||
$
|
2,585
|
$
|
2,623
|
$
|
(986
|
)
|
||||
Details
of the company’s income taxes:
|
||||||||||
Earnings
(loss) before income taxes
|
||||||||||
Canadian
|
$
|
13,202
|
$
|
3,092
|
$
|
(7,740
|
)
|
|||
United
States
|
(2,103
|
)
|
(953
|
)
|
(5,879
|
)
|
||||
Other
|
(379
|
)
|
(1,150
|
)
|
4,209
|
|||||
$
|
10,720
|
$
|
989
|
$
|
(9,410
|
)
|
As
at August 31,
|
|||||||
2006
|
2005
|
||||||
Future
income tax assets
|
|||||||
Long-lived
assets
|
$
|
4,453
|
$
|
4,902
|
|||
Provisions
and accruals
|
7,315
|
7,406
|
|||||
Government
grants
|
−
|
209
|
|||||
Deferred
revenue
|
486
|
318
|
|||||
Share
issue expenses
|
531
|
590
|
|||||
Research
and development expenses
|
8,527
|
7,292
|
|||||
Losses
carried forward
|
18,118
|
18,424
|
|||||
39,430
|
39,141
|
||||||
Valuation
allowance
|
(38,543
|
)
|
(38,406
|
)
|
|||
887
|
735
|
||||||
Future
income tax liabilities
|
|||||||
Research
and development tax credits
|
(887
|
)
|
(735
|
)
|
|||
Future
income tax assets, net
|
$
|
−
|
$
|
−
|
Canada
|
United
States
|
|||||||||
Year
of expiry
|
Federal
|
Provinces
|
and
Other
|
|||||||
2008
|
$
|
1,252
|
$
|
92
|
$
|
1,857
|
||||
2009
|
5,186
|
394
|
599
|
|||||||
2010
|
4,677
|
327
|
266
|
|||||||
2011
|
168
|
86
|
-
|
|||||||
2013
|
-
|
-
|
876
|
|||||||
2015
|
1,666
|
1,670
|
-
|
|||||||
2022
|
-
|
-
|
9,406
|
|||||||
2023
|
-
|
-
|
11,621
|
|||||||
2024
|
-
|
-
|
6,700
|
|||||||
2025
|
-
|
-
|
6,690
|
|||||||
2026
|
1,694
|
1,696
|
2,737
|
|||||||
Indefinite
|
1,702
|
1,775
|
1,996
|
|||||||
$
|
16,345
|
$
|
6,040
|
$
|
42,748
|
Years
ended August 31,
|
||||||||||
2006
|
2005
|
2004
|
||||||||
Basic
weighted average number of shares
outstanding
(000’s)
|
68,643
|
68,526
|
66,020
|
|||||||
Plus
dilutive effect of:
|
||||||||||
Stock
options (000’s)
|
502
|
422
|
502
|
|||||||
Deferred
share units (000’s)
|
31
|
8
|
−
|
|||||||
Restricted
share units (000’s)
|
99
|
8
|
−
|
|||||||
Restricted
stock awards (000’s)
|
−
|
17
|
93
|
|||||||
Diluted
weighted average number of shares outstanding (000’s)
|
69,275
|
68,981
|
66,615
|
|||||||
Stock
awards excluded from the calculation of the diluted weighted average
number of shares outstanding because their exercise price was greater
than
the average market price of the common shares (000’s)
|
1,628
|
1,962
|
2,128
|
As
at August 31,
|
|||||||
2006
|
2005
|
||||||
Commercial
paper denominated in Canadian dollars, bearing interest at annual
rates of
3.92% to 4.31% in 2006 and 2.44% to 2.75% in 2005, maturing on
different
dates between September 2006 and January 2007 in fiscal 2006, and
September 2005 and January 2006 in fiscal 2005
|
$
|
104,437
|
$
|
104,883
|
Cash
|
Non-interest
bearing
|
|
Short-term
investments
|
As
described above
|
|
Accounts
receivable
|
Non-interest
bearing
|
|
Accounts
payable and accrued liabilities
|
Non-interest
bearing
|
|
Long-term
debt
|
As
described in note 10
|
Contractual
amounts
|
Weighted
average contractual forward rates
|
||||||
As
at August 31, 2005
|
|||||||
September
2005 to August 2006
|
$
|
26,000
|
1.2630
|
||||
September
2006 to November 2007
|
7,600
|
1.2500
|
|||||
As
at August 31, 2006
|
|||||||
September
2006 to August 2007
|
$
|
37,000
|
1.1676
|
||||
September
2007 to June 2009
|
26,800
|
1.1261
|
Year
ended August 31, 2006
|
||||||||||
Telecom
Division
|
Life
Sciences and Industrial Division
|
Total
|
||||||||
Sales
|
$
|
107,376
|
$
|
20,877
|
$
|
128,253
|
||||
Earnings
from operations
|
$
|
6,679
|
$
|
1,383
|
$
|
8,062
|
||||
Unallocated
items:
|
||||||||||
Interest
and other income
|
3,253
|
|||||||||
Foreign
exchange loss
|
(595
|
)
|
||||||||
Earnings
before income taxes
|
10,720
|
|||||||||
Income
taxes
|
2,585
|
|||||||||
Net
earnings for the year
|
$
|
8,135
|
||||||||
Government
grants (note 15)
|
$
|
(1,307
|
)
|
$
|
−
|
$
|
(1,307
|
)
|
||
Amortization
of capital assets
|
$
|
6,689
|
$
|
1,228
|
$
|
7,917
|
||||
Stock-based
compensation costs
|
$
|
962
|
$
|
70
|
$
|
1,032
|
||||
Impairment
of long-lived assets (note 4)
|
$
|
−
|
$
|
604
|
$
|
604
|
||||
Capital
expenditures
|
$
|
3,049
|
$
|
329
|
$
|
3,378
|
Year
ended August 31, 2005
|
||||||||||
Telecom
Division
|
Life
Sciences and Industrial Division
|
Total
|
||||||||
Sales
|
$
|
80,120
|
$
|
17,096
|
$
|
97,216
|
||||
Earnings
(loss) from operations
|
$
|
763
|
$
|
(962
|
)
|
$
|
(199
|
)
|
||
Unallocated
items:
|
||||||||||
Interest
and other income
|
2,524
|
|||||||||
Foreign
exchange loss
|
(1,336
|
)
|
||||||||
Earnings
before income taxes
|
989
|
|||||||||
Income
taxes
|
2,623
|
|||||||||
Net
loss for the year
|
$
|
(1,634
|
)
|
|||||||
Amortization
of capital assets
|
$
|
6,504
|
$
|
2,588
|
$
|
9,092
|
||||
Stock-based
compensation costs
|
$
|
897
|
$
|
66
|
$
|
963
|
||||
Capital
expenditures
|
$
|
1,408
|
$
|
93
|
$
|
1,501
|
Year
ended August 31, 2004
|
||||||||||
Telecom
Division
|
Life
Sciences and Industrial Division
|
Total
|
||||||||
Sales
|
$
|
58,882
|
$
|
15,748
|
$
|
74,630
|
||||
Loss
from operations
|
$
|
(5,557
|
)
|
$
|
(5,013
|
)
|
$
|
(10,570
|
)
|
|
Unallocated
items:
|
||||||||||
Interest
and other income
|
1,438
|
|||||||||
Foreign
exchange loss
|
(278
|
)
|
||||||||
Loss
before income taxes
|
(9,410
|
)
|
||||||||
Income
taxes
|
(986
|
)
|
||||||||
Net
loss for the year
|
$
|
(8,424
|
)
|
|||||||
Amortization
of capital assets
|
$
|
6,643
|
$
|
3,372
|
$
|
10,015
|
||||
Stock-based
compensation costs
|
$
|
417
|
$
|
32
|
$
|
449
|
||||
Impairment
of long-lived assets (note 4)
|
$
|
620
|
$
|
−
|
$
|
620
|
||||
Restructuring
and other charges (note 4)
|
$
|
−
|
$
|
1,261
|
$
|
1,261
|
||||
Capital
expenditures
|
$
|
607
|
$
|
244
|
$
|
851
|
As
at August 31,
|
|||||||
2006
|
2005
|
||||||
Telecom
Division
|
$
|
93,853
|
$
|
64,655
|
|||
Life
Sciences and Industrial Division
|
11,339
|
11,449
|
|||||
Unallocated
assets
|
113,967
|
114,853
|
|||||
$
|
219,159
|
$
|
190,957
|
As
at August 31,
|
|||||||
2006
|
2005
|
||||||
Telecom
Division
|
$
|
22,545
|
$
|
16,092
|
|||
Life
Sciences and Industrial Division
|
4,597
|
4,278
|
|||||
$
|
27,142
|
$
|
20,370
|
Years
ended August 31,
|
||||||||||
2006
|
2005
|
2004
|
||||||||
United
States
|
$
|
59,457
|
$
|
56,282
|
$
|
40,019
|
||||
Canada
|
8,767
|
6,830
|
5,818
|
|||||||
Latin
America
|
8,380
|
3,127
|
3,547
|
|||||||
76,604
|
66,239
|
49,384
|
||||||||
Europe,
Middle East and Africa
|
32,379
|
19,396
|
13,706
|
|||||||
Asia-Pacific
|
19,270
|
11,581
|
11,540
|
|||||||
$
|
128,253
|
$
|
97,216
|
$
|
74,630
|
As
at August 31,
|
|||||||
2006
|
2005
|
||||||
Canada
|
$
|
51,724
|
$
|
35,690
|
|||
United
States
|
3,758
|
5,601
|
|||||
$
|
55,482
|
$
|
41,291
|
Years
ended August 31,
|
|||||||||||||
2006
|
2005
|
2004
|
|||||||||||
Net
earnings (loss) for the year in accordance with Canadian
GAAP
|
$
|
8,135
|
$
|
(1,634
|
)
|
$
|
(8,424
|
)
|
|||||
Stock-based
compensation costs
|
a
|
)
|
−
|
−
|
(867
|
)
|
|||||||
Unrealized
losses on forward exchange contracts
|
b
|
)
|
−
|
(1,286
|
)
|
(280
|
)
|
||||||
Net
earnings (loss) for the year in accordance with U.S.
GAAP
|
8,135
|
(2,920
|
)
|
(9,571
|
)
|
||||||||
Other
comprehensive income (loss)
|
|||||||||||||
Foreign
currency translation adjustment
|
12,322
|
15,669
|
5,969
|
||||||||||
Unrealized
gains on forward exchange contracts
|
b
|
)
|
5,394
|
2,313
|
689
|
||||||||
Reclassification
of realized gains on forward exchange contracts in net earnings
(loss)
|
b
|
)
|
(2,880
|
)
|
(65
|
)
|
−
|
||||||
Comprehensive
income (loss)
|
$
|
22,971
|
$
|
14,997
|
$
|
(2,913
|
)
|
||||||
Basic
and diluted net earnings (loss) per share in accordance with
U.S.
GAAP
|
$
|
0.12
|
$
|
(0.04
|
)
|
$
|
(0.14
|
)
|
|||||
Basic
weighted average number of shares outstanding (000’s)
|
68,643
|
68,526
|
66,020
|
||||||||||
Diluted
weighted average number of shares outstanding (000’s)
|
69,275
|
68,981
|
66,615
|
As
at August 31,
|
|||||||||||||
2006
|
2005
|
2004
|
|||||||||||
Shareholders’
equity in accordance with Canadian GAAP
|
$
|
196,234
|
$
|
173,400
|
$
|
157,327
|
|||||||
Forward
exchange contracts
|
b
|
)
|
5,451
|
2,937
|
1,975
|
||||||||
Goodwill
|
(11,908
|
)
|
(11,042
|
)
|
(10,008
|
)
|
|||||||
Shareholders’
equity in accordance with U.S. GAAP
|
$
|
189,777
|
$
|
165,295
|
$
|
149,294
|
Share
capital
|
Contributed
surplus
|
Deficit
|
Deferred
stock-based compensation costs
|
Other
capital
|
Accumulated
other comprehensive income
|
Shareholders’
equity
|
||||||||||||||||
Balance
as at August 31, 2003
|
$
|
565,291
|
$
|
1,519
|
$
|
(454,588
|
)
|
$
|
(1,278
|
)
|
$
|
5,429
|
$
|
5,219
|
$
|
121,592
|
||||||
Net
loss for the year
|
−
|
−
|
(9,571
|
)
|
−
|
−
|
−
|
(9,571
|
)
|
|||||||||||||
Stock-based
compensation costs
|
1,737
|
−
|
−
|
339
|
(760
|
)
|
−
|
1,316
|
||||||||||||||
Foreign
currency translation adjustment
|
−
|
−
|
−
|
−
|
−
|
5,969
|
5,969
|
|||||||||||||||
Unrealized
gains on forward exchange contracts
|
−
|
−
|
−
|
−
|
−
|
689
|
689
|
|||||||||||||||
Public
offering (note 13)
|
29,164
|
−
|
−
|
−
|
−
|
−
|
29,164
|
|||||||||||||||
Exercise
of stock options (note 13)
|
254
|
−
|
−
|
−
|
−
|
−
|
254
|
|||||||||||||||
Share
issue expenses (note 13)
|
(137
|
)
|
−
|
−
|
−
|
−
|
−
|
(137
|
)
|
|||||||||||||
Premium
on resale of share capital
|
−
|
18
|
−
|
−
|
−
|
−
|
18
|
|||||||||||||||
Balance
as at August 31, 2004
|
596,309
|
1,537
|
(464,159
|
)
|
(939
|
)
|
4,669
|
11,877
|
149,294
|
|||||||||||||
Net
loss for the year
|
−
|
−
|
(2,920
|
)
|
−
|
−
|
−
|
(2,920
|
)
|
|||||||||||||
Stock-based
compensation costs
|
1,213
|
−
|
−
|
(776
|
)
|
425
|
−
|
862
|
||||||||||||||
Foreign
currency translation adjustment
|
−
|
−
|
−
|
−
|
−
|
15,669
|
15,669
|
|||||||||||||||
Unrealized
gains on forward exchange contracts
|
−
|
−
|
−
|
−
|
−
|
2,248
|
2,248
|
|||||||||||||||
Exercise
of stock options (note 13)
|
148
|
−
|
−
|
−
|
−
|
−
|
148
|
|||||||||||||||
Share
issue expenses (note 13)
|
(6
|
)
|
−
|
−
|
−
|
−
|
−
|
(6
|
)
|
|||||||||||||
Balance
as at August 31, 2005
|
597,664
|
1,537
|
(467,079
|
)
|
(1,715
|
)
|
5,094
|
29,794
|
165,295
|
|||||||||||||
Net
earnings for the year
|
−
|
−
|
8,135
|
−
|
−
|
−
|
8,135
|
|||||||||||||||
Stock-based
compensation costs
|
−
|
−
|
−
|
344
|
610
|
−
|
954
|
|||||||||||||||
Foreign
currency translation adjustment
|
−
|
−
|
−
|
−
|
−
|
12,322
|
12,322
|
|||||||||||||||
Unrealized
gains on forward exchange contracts
|
−
|
−
|
−
|
−
|
−
|
2,514
|
2,514
|
|||||||||||||||
Exercise
of stock options (note 13)
|
557
|
−
|
−
|
−
|
−
|
−
|
557
|
|||||||||||||||
Reclassification
of stock-based compensation costs upon exercise of stock awards
(note
13)
|
200
|
−
|
−
|
−
|
(200
|
)
|
−
|
−
|
||||||||||||||
Balance
as at August 31, 2006
|
$
|
598,421
|
$
|
1,537
|
$
|
(458,944
|
)
|
$
|
(1,371
|
)
|
$
|
5,504
|
$
|
44,630
|
$
|
189,777
|
As
at August 31,
|
|||||||||||||
2006
|
2005
|
2004
|
|||||||||||
Foreign
currency translation adjustment
|
|||||||||||||
Current
year
|
$
|
12,322
|
$
|
15,669
|
$
|
5,969
|
|||||||
Cumulative
effect of prior years
|
26,857
|
11,188
|
5,219
|
||||||||||
39,179
|
26,857
|
11,188
|
|||||||||||
Unrealized
gains on forward exchange contracts
|
b
|
)
|
|||||||||||
Current
year
|
2,514
|
2,248
|
689
|
||||||||||
Cumulative
effect of prior years
|
2,937
|
689
|
−
|
||||||||||
5,451
|
2,937
|
689
|
|||||||||||
$
|
44,630
|
$
|
29,794
|
$
|
11,877
|
d) |
Elimination of deficit by reduction of share
capital
|
e) |
New accounting standards and
pronouncements
|